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THE COLLEGE OF 
FAMILY PHYSICIANS 
OF CANADA 
LE COLLEGE DES 
MEDECINS DE FAMILLE 
DU CANADA 
WHY FAMILY MEDICINE? 
Family medicine offers challenges, flexibili ty, and tremendous diversity. Famil y phys icians provide comprehensive care for patients and 
their families w ithin the community, w ith a focus on prevention, management of chronic disease, and coordination of care. Famil y 
physicians have the opportun ity to provide care in a variety of settings, including medica l clini cs, emergency departments, acute care 
settings, and in patients' homes. Some work internationally prov iding care to people in low-resource countries. With many physicians 
working in teams and w ith other health profess ionals such as nurses, occupational therapists, and nutritioni sts, the field is also 
becoming more coll aborati ve. 
Training for a career in family medicine 
Famil y phys icians are often the first line of care and care fo r patients w hen they present w ith i llness through the management of 
chronic diseases. 
Students shou ld consider family medicine if they: 
• Are interested in being generalists; famil y phys icians speciali ze in breadth rather than depth of knowledge, amassing an equal but 
diffe rent knowledge base to specia lists 
• Enjoy diagnos ing and managing the undifferentia ted patient: family phys ic ians have the opportun ity to see patients from their f irst 
presentation, and to manage their care both independently and in partnership w ith other medica l professionals in the community 
• Are attracted to a number of di fferent specia lties and want their practi ces to encompass a w ide range of disease presentations 
• W ant flex ibili ty and control over their schedules 
• W ant to form long-term relationships w ith their patients 
Diversi ty in patients, work setti ngs, and schedu les makes family medic ine the most flex ible career in medici ne. A variety of practice 
models, the opportuni ty to job share, and the abil ity to shape thei r practi ces offer family physicians a great dea l of choice. The high 
demand for family physicians in almost every region of Ca nada also opens many opportunit ies fo r locum posi tions and travel. 
Some family physic ians also choose to incorporate a focused area into thei r scope of practi ce. Nearl y one-third of family medicine 
res idents complete additional training to better prepare them for the patients they wi ll encounter w hile serving thei r community's 
specific needs. 
Students may also pursue training through Enhanced Skills (R3) programs, ranging from a few months to one year. In 2008-2009, 196 
R3 positions were available in Canada for fami ly medicine res idents. At some schools, prospective students can secure funding to 
support an R3 training program based on their unique ca reer goa ls; ava ilability and focus va ry by school. Exa mples of Enhanced Ski ll s 
programs include emergency medicine, sports medic ine, geri atri cs, women's health (obstetri cs, gynecology), adolescent medic ine, 
mental hea lth, research training, substance abuse treatment, international hea lth, and HIV/AIDS. 
Income for family physicians varies w idely depending on hours, location, incenti ves, and type of practi ce. Within a group practice, 
family phys icians should earn over $175,000 after overh ead and before taxes. 
Incentives for practic ing in underserved areas range from higher sa laries and higher fee-for-service payments to loan forgiveness, lump-
sum payments, increased continuing medica l educa tion, and holiday support . Most rural phys icians have lower overhead costs and the 
opportuni ty to earn higher income for performing procedures that would otherwi se be carri ed out by other specialists . 
In the midst of Canada-wide and global shortages of fami ly phys icians, the Canadian government is rea lizing that a robust primary care 
system is vital to the sustainabi li ty of our health care system. Will you be the future of family medicine? 
For more information please see http://www.cfpc.ca/whyfamilymedicine 
This is a condensed v~rsion of this ~ocument. For the complete pamphlet with more detailed information, please send an email to 
soms@cfpc.ca to rece1ve a full vers1on electronically. 
Authored by: lan Scott MD MSc DO HS CCFP FRCPC FCFP (Vancouver, BC) 
Goldis Chami BA BSc (Vancouver, BC) 
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FRONT: The left half of the image shows what we as physicians can see. There are few other areas of 
the body where knowledge of anatomy is as crucial in understanding disease pathology. The airway, 
ea r, and nose all require an optimal shape to function; the lungs need space to expand . Physiology 
allows us to understand the integration of structure with function . The right half of the image shows 
what we cannot see, and rather what we must think. It is essential to look beyond the obvious, 
considering the underlying anatomy and physiology, in order to understand . 
2 
Allin the Head 
Pencilla Lang (Meds 2011) 
I n the middle ages, a common treatment for fo reign bodies in the throat was to ca ll upon St. Bla ise, the "defender of the throat": 
"Piece of bone or thorn. whatever thou art, just as Jesus Christ 
caused Lazarus to come forth from the tomb and Jonah from the belly 
of the whale (here the patient should be eized by the throat) in the 
name of St. Blaise, martyr and servant of Christ, 1 order three to 
come up or go down" - Aetius of Amida (4th century AD)1 
Other early remedi es included the use of the dung of lambs, the 
j uices of a snai l pi erced with a needle, the ashes of burnt wa llow 
mixed with hay, or cent ipedes mi xed with pigeons' dung applied 
externa lly. 2 
In Grade 5 I wrote a poem in which I described the virtues and 
drawbacks of each medica l spec ialty. In it, oto laryngology held the 
double distincti on of being the mo t di ffic ult specialty to pronounce 
and spe ll. Banished fro m my thoughts fo r these reasons, I gave 
di eases of the ears, no e and throat little thought until I was 
capti vated by the complexity and mystery of the sphenoid bone in 
medica l chool. Over centuries, the study of anatomy and phys io logy 
have debunked many superstitions. We now know that poisons 
dropped into the ear do not have the same effect as poisons 
swa llowed (as was be lieved during Shakespeare's time), and that 
ting ling in the left ear is not caused by our peers speaking poorl y of 
us. Equa lly many mysteries remain . What causes allergic rhini tis 
ra tes to ri se a nd fa ll a m o ng po pul a ti ons? W ha t is th e 
pathophys io logy of mitochondrial hearing loss? Are minimall y 
invasive procedures an effective way to remove tumours with less 
damage to surrounding tissues? 
The study of ENT covers a vast spectrum of di seases and 
crosses many medical spec ialtie , from wimmer's ears and sore 
throats that frequent primary care offices, to problematic difficult 
airways in anesthesia, and tumours visualized only through imag ing. 
Thi s issue of the UWOMJ is an eclecti c mi x of topics. We bring you 
articles on the SoundBi te hearing aid that a ll ows a person to 'hear' 
with the ir teeth, free-flap oromandibu lar reconstructi on techniques, a 
new transoral roboti c surgery procedure, the debate surrounding 
fund ing o f cochlear implants in Canada, and many more. 
Since it 's establi shment in 1930, the UWOMJ has been 
continua ll y changing and growing to meet the needs of our 
communi ty. I fi rst got in volved with the VWOMJ as a junior 
departmental editor in 2007, and over the years I have had the 
pri vi lege to witness extraordinary growth in thi s journal. Highli ghts 
have incl uded the forg ing of a partnership with CU Adverti sing 
all owing the printing and di stributi on of the UWOMJ free of charge 
to readers, a beautiful new layout, a new online presence at http :// 
www. uwomj .com/ (please do drop by and visit !), and the creation of 
feature arti cle, departmenta l and artwork awards to recognize the 
contributi ons of UWO medical students. The editorial team expects 
the 2011-201 2 year to bring even more change - keep your eyes 
peeled for an interacti ve online component to the journal! 
Despite the changi ng landscape, the UWOM J remains a 
publi cation of work written by and for UWO medica l and denta l 
students. Our objectives are twofold : to educate and enlighten by 
encouraging the sharing of in fo rmation and idea between student , 
teachers and our medi ca l community, and to a ll ow UWO medical 
students to ex perience the process of craft ing their own research, 
rev iew and case study arti cles. We in vite you to join us this year a 
an author, supporter or reader. 
REFERENCES 
I. Ro lleston, J. D. Laryngology and Folk-Lore. The Journal of Laryngology 
& Otology. 1942;57( 12) : 527-532 . 
2. Dani el CL, tevan CM. Encycl op~tdia of uperst itions, Folklore, and the 
Occult Sciences of the Worl d (Volume I). Detroit: Gale Resea rch Co; 
1903 . 
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Microvascular free flap transfer for 
reconstruction of oromandibular defects 
Brennan Ballantyne {Meds 2014}, Sandeep Dhal iwal {Meds 2013} 
Faculty Reviewer: Dr. Anthony Nichols, Department of Otolaryngology- Head and Neck Surgery, UWO 
R econstruction of the mandible present unique cha ll enges to the head and neck surgeon. A lthough mandibul ar defect can resu lt from trauma, infect ion, congeni ta l deformities, or 
osteonecros is, it most commonl y occurs fo ll owing ablative surgery 
fo r the treatment of benign o r malignant neoplasms. Primary intra-
bony mandibular carci noma is rare; there fo re, the involvement of the 
lower jaw is usua lly secondary to neoplasm ex tension from the o ra l 
cavity or the o ropharynx. A lthough tumour resecti on to ensure 
patient survival is a surgeon's primary concern , not to be overlooked 
are aesthetic and quality of life parameters. The mandible serves to 
provide shape for the lower third of the face, a border between the 
face and neck, and po itions the mentum and lower lip. Functionally, 
it supports masticatory forces and the mandibu lar dentiti on as we ll as 
the tongue in both pos it ion and function . On average, it must su ta in 
a force of 726 with a maximal force occurring at the molar teeth of 
4346 N. 1 
The use of nonvascu larized techniques for repa iring the 
mandible provides excell ent results in certai n pati ents. For example, 
allopl asti c implants, such as those composed of titanium , provide 
rapid recon truction options without the need for ha rvest ing 
autogenous free fl aps. However, the di sadvantage of this method is 
the ri sk of pl ate fracture, pl ate extrus ion, and exposure with 
subseq uent infection . A lternat ive ly, free tissue transfer provides 
superior re ults in repai ring mandibular defects in most ituati on as 
an abdundance of literature is available to sugges t that such 
techniques improve patients' quality of li fe .2·3 Figures 1-4 outline the 
basic pr incip les of tum o ur resec ti o n a nd oro ma ndibul ar 
recon !ruction . Currently, there are severa l urgica l option ava ilable 
for the repai r of oromandibula r defect us ing mi crova cul a r free fl ap 
methods. 
FIBULAR OSTEOCUTANEOUS FREE FLAP 
The fibul ar free fl ap has been deemed the " workhorse" donor s ite for 
reconstruction of oromandibul a r defects because o f it versati lity, 
frequent use, and success rates that approach upwards of 95%.4-6 The 
fibu lar fl ap i vascularized by the peronea l artery and its two 
assoc iated venae comitantes. The entire fibul a (- 25cm) can be 
harvested except for mall segments at the di ta l and prox imal ends 
to preserve joint stab ility and ca n be used with the fl exor ha lluc is 
longus muscle or a sk in paddle for additiona l oft ti ssue repair.7 As 
such, it is the natura l choice when longer lengths of bone are needed 
to repa ir a surg ica l resec ti on and an exce ll ent cho ice for 
reconstructions that require primaril y bone or where the mandibl e is 
atrophi c.8 The fibu lar fl ap prov ide enough bone fo r supporting 
dental implantati on and is an idea l match fo r the contour of the 
natura l j aw anatomy. 
Critic isms o f the fibul a r free flap have surrounded the he ight 
di screpancy compared to the nati ve mandible , and the inability to 
reconstruct la rge-sca le so ft ti ssue defects (ie. those resulting from 
tota l g lo sectomies) . otwi thsta nding, continued innovation has 
resulted in the development of a "doubl e-barre l" technique that folds 
the fibu la onto it e lf and the reby effecti vely doubles the height of the 
mandibl e avai lable for osseo integrated implants.9 Large soft ti ssue 
defect can be repaired by u ing a second fl ap such a the radial 
fo rearm free fl ap o r pectora l is myocutaneous flap . 1° Finally donor 
site morbidi ty is a pa rticu lar concern . Although most patients will 
experi ence a hindrance in ankle planta r- and dors i-flexion range of 
moti on and trength te ting, tudies have hown that thi decrease is 
not enough to impact patients' quality of life. 11 
SCAPULAR OSTEOCUTANEOUS FREE FLAP 
The capular osteocutaneous free fl ap ( OFF) is a versatile fl ap for 
mandibula r reconstruction as it enables repair of many bone defects 
while imultaneou ly providing an abundance of soft tissue for 
repairing defects that involve fac ia l ski n and o ra l mucosa. The SOFF 
can provide up to 14 em of capular bone, and is ba ed on the 
circumflex scapular artery and vei n.12 The branching pattern of the 
vasculature permits harvesting a number of fasciocutaneous and 
osteocutaneous flaps . Often, part of the lati s imus dors i and/or 
erratu ante rio r va cularized by the thoracodorsal a rtery and ve in 
can be incorporated to provide more soft ti ssue bulk. Neverthe le , 
the limited length, wid th and integrity of bone ava ilable makes the 
scapul ar fl ap unsuitable for denta l implants. Decrea ed range of 
shoulder moti on can occur if aggress ive post-operati ve physical 
therapy is not carried out. However, near nonnal function can be 
obtai ned if proper rehabi litation i pursued. A drawback of the fl ap is 
the n eed to change the position of the pati ent during surgery from 
upme to latera l fo r harvesting. Thi s prevents harvest of the flap at 
the same time as the tumor ablation, whi ch may prolong the case. 
SCAPULAR TIP OSSEOUS FREE FLAP 
Preferred by the head and neck team at the University of Western 
Ontario, one increasing ly popular a lternative to the trad itional 
scapula r fl ap is the scapu la r tip osseous free fl ap based on the angular 
branch of the thoracodorsal a rtery. Thi s modified fl ap enable the use 
of up to 20 em of bone, is often harvested with the lati s imus do rsi 
and/or . serratu anterio r muscles, and provides the option of 
1 ~ crea _mg the kin and musc le pedicle length by a lso extending the 
dissecti on to the subscapular artery and ve in. Thi s a ll ows the pedic le 
~ength to reach upwards of I 7 em compared to 6 em from the OFF. 
3 Furthermore, the triangu_lar nature of the infe rior angle o f the 
scapu la a ll ow for harvestmg a greater vari ety of 3-dimensiona l 
shapes: . These reco ns tru c tion adva ntages - increased bone 
ava il abil ity, mcreased pedic le length , and bone geometry _ offered by 
tl~e scapula r tip free fl ap have been shown to be associated with 
highly successfu l surgica l outcomes .1 4 
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ILIAC CREST OSTEOCUTANEOU FREE FLAP 
The iliac crest osteocutaneou free fl ap (I OFF) offers unique 
advantages ~ver the fibul ar fl ap with re pect to quality and quantity 
of bone ava ilable. The natura l shape of the ili ac crest resembles the 
mandibl e anatomicall y, and therefore minimal osteotomy is required 
to form the neomand1ble. For example, the hemimandible can be 
recreated from the ip ilateral ilium using the anterior superior ili ac 
pme to restore the mandibular ang le. 15 The avai lable bone has a 
height comparable to the nat ive dentate mandibl e, and is therefore an 
optunal substrate for denta l implantat ion. However, the surgery is 
very complex compared to newer options, and has been largely 
supplanted by the fibular free fl ap as the primary choice. The ICOFF 
blood. uppl y is based upon deep c ircumflex iliac artery and vein7 
The mtem al oblique mu cle is thin and pliable and can be 
manoeuvred independently of the bone easi ly and reliably.I S A 
s1gmficant drawback to the u e of the ICOFF is that harve t invol ve 
the release of the ~bdomina l muscles to access the peritoneal space 
leadmg to morbidity at the donor site, inc luding issues of hemi a 
preventiOn a t the abdominal wa ll , ga it a lte ration , se nso ry 
disturbance , and acute pain . There fore, ignificant rehabilitation is 
often required to rega in normal ambulation. 
RADIAL FOREARM FREE FLAP 
The radi al forearm free fl ap (RFFF) has some of the best blood 
supply compared to other tissue options, is well innervated for good 
recovery of sensory function , and additional bulk can be added by 
mcorporatmg the brachioradiali s musc le.7 The arterial supply to the 
RFFF IS ba ed on the radial artery. There fore, an Allen test must be 
performed before harvesting thi s flap to ensure the ulnar artery can 
adequate ly. upply the hand. Venou drainage occurs through the 
venae com1tantes of the radial artery or via the cephalic vein . 
. T~e .RFFF o~ers a large area, thin and pliable skin segment 
which IS Ideal . for mtra-oral reconstruction thu making it the most 
~1de ly u ed microvascular free flap in all head and neck surgery.I 6 It 
IS used more for defects of the oral cavity, oropharynx, nasopharynx , 
and tongue as a fasciocutaneous flap , but the option of using it as an 
osteocutaneous fl ap by including bone is available. I6 Approximately 
I 0 em of bone can be taken . A lthough it is strong cortica l bone, it 
tends not to be very thick as on ly 113 of the cro -sectional area of 
the radial bone can be taken without increasing the ri sk of stress 
fracture to the arm. As such, RFFF is best suited for latera l or ramus 
mandibular defects that require minimal amounts of bone but an 
abundance of so ft tissue. Known limitations include the lack of 
availab le bone for osteotomy, and morbidity at the donor site due to 
the bulk of remaining bone. Fracture rate foll owing RFFF 
approaches 18% of cases, 17 but prophylactic intemal fi xation of the 
radius has been shown to reduce thi s fracture rate to as low as 4.5%. 
18 Tapering edges of graft in a "boat tail" can also reduce the risk of 
postoperative fractures as can a prolonged period of immobilization 
(3 weeks).8 For these reasons, on ly small bony defects of the 
mandible are repaired using radial forearm flap, or it is combined 
with other donor sites (ie. iliac, fibular or scapu lar). 19 
POST-OP I OUTCOMES I COMPLICATIONS 
Success rates for free tissue transfer at most high volume centers is 
high, exceeding 95% or higher.1·10 However, close postoperative 
monit_oring can detect complications that may affect ti ssue viability, 
allowmg for early intervention to minimize recipient site morbidity. 
The most common complications that threaten the viabi lity of the 
free flap results from vessel thrombosis, predominantly in the veins. 
20 Hematomas as a result of the surgery or the failure to place an 
adequate suction drain are also well-known complications. Other 
problems that have been cited in the literature as causes of morbidity 
include pulmonary problems, prolonged ventilatory support, and 
acute alcohol withdrawaJ.I 9 
Postoperati vely, most pat ients are transferred to the intensive 
care unit fo r an average of 2.44 days, and an average ho pita! stay of 
2-4 weeks.21 The most common method of monitoring the graft 
includes assessment of flap co lour, pin prick and bleeding rate, 
capi ll ary refill , ski n surface temperature, and Doppler igna l 
investiga ti ons. Other methods less commonly used are e lectri ca l 
impedance pl ethysmography, Ia er Doppler, photoplethy mography, 
tran cutaneous pulse oximetry, and scintigraphy20 
. Pat ient are fo ll owed long term to ensure that the flap remain 
VIable, the aesthetic goals of the patient have been reached, and that 
the patient is achieving fu nctiona l rehabilitation . A 10 year fo llow up 
of these patients has revea led that aesthetic outcomes are achi eved in 
90% of patients, 70% have regular diets and the remainder have soft 
di ets, 85% have easily intell igible speech, and greater than 90% have 
preserved bone height, indicating that there is minimal bone 
re orption22 These re ults hi ghlight the notion that microvascul ar 
free fl ap reconstruction has achi eved excell ent outcome th at are 
ce lebrated by health care teams and their pat ients. 
FUTURE DIRECTIONS I CONCLUSION 
Head and neck reconstructi ve urgery has seen monumenta l advances 
in the past few decade . State-of- the-art microva cular equi pment, 
along w1th the development of numerou free flap ti ssue options ha 
resulted in vascul arized osseou free fl ap transfer becoming the 
preferred method for reconstruction leadi ng to a dramatic rise in 
rep~i: ucce rate.23 Currentl y, in the field of oromandibular repai r, 
excit.mg new advances are continuall y being made to improve 
surg ica l outcomes. For example, th e co ncept of di trac tion 
osteogenesis, originally deve loped for orthopedi c appli cation to 
l e ~gthen bone, is begi~n~ng to be used by head and neck surgeons. 
DistractiOn osteogenesis mvolves an extemal mechani ca l device that 
separates two bony surfaces. The length of the di stract ion is then 
progressive ly lengthened over everal days to a llow a gap for new 
bone to form during the consolidation phase. It is used for patients 
With poor functiOnal outcome following reconstruction due to scar 
fonnation or inadequate bone length 8 · 12 Moreover, the fi e ld of ti ssue 
eng ineering also holds promise for the future of head and neck repair. 
The use of recombmant bone morphogenic protein (rhBMP-2) has 
been shown to stimulate bone regenerati on without the use o f 
autologous grafts in an in vitro setting.24 Additional ly, in vivo animal 
and cadave~ic studies have demonstrated the utility of ti ssue 
engm~enng m developmg bone grafts for the use of reconstructing 
mand.Ibular defects.25·26 In thi s manner, the deve lopment of 
techniques that allow for the transfer of cultured cell substrate to 
regenerate portions of the mandible w ill likely offer the next step in 
the evolution of mandibular reconstruction . 
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Malignant airway obstruction: treating central 
airway obstruction in the oncologic setting 
Esther Chan (Meds 2013), Niran Argintaru (Meds 2014) 
Faculty Reviewer: Dr. Belal Ahmad, Department of Radiation Oncology, UWO 
Ob !ruction of the centra l airways, the trachea and main stem bronchi, may result from many disease processes including malignant growth . It is estimated that in the United States, 
malignant neoplasms will cause centra l airway obstruction (CAO) in 
80,000 cancer patients a year. 1 lt is estimated that 20% of these 
patients wi ll experi ence ignificant morbidity due to per i tent 
cough, dyspnea, and obstructive pneumonia, and as many as 35-40% 
of lung cancer patients die due to complications resulting from loco-
regional di sease. 1•2 While most treatments for malignant CAO are not 
curative, they have been shown to improve resp iratory function , 
avoid mortality, and improve quality of life.3.4.5•6 Many different 
strategies for managing malignant airways exist. Choosing the best 
one depends on pat ient factors such as presence of co-morbidities, 
medical stability, the nature of the underlying tumour, and overall 
prognosis. Non-patient related factors such as ex pertise of medical 
staff and avai labili ty of technology also great ly impact the mode of 
treatment chosen.2 This article presents current treatment options for 
malignant CAO, spec ifically, therapeutic bronchoscopy, radiotherapy, 
and surgical resection . 
CAUSES OF MALIGNANT CENTRAL AIRWAY 
OBSTRUCTION 
The most common mali gnant causes of central a irway obstructions 
are direct extension into the airway lumen by extrinsic tumours (fig. 
lb).2 Of these tumours the most common types are bronchogeni c 
carcinomas (i.e. small cell lung cancer and non-small cell lung 
cancer), fo llowed by esophageal and thyroid carcinomas2 Primary 
tumours of the trachea and bronchi , or intrinsic central airway 
tumours (fig. Ia) are re latively rare. Seventy to eighty percent of 
these tumours are of squamous cell or adenoid cystic carcinoma type. 
2 Squamous cell carcinomas typically occur later in life and more 
frequently in men and smokers, while adenoid cystic carcinomas are 
found in younger patients and are not related to exposure to smoking 
or to the sex of the patient3 Occasionally, but less frequent ly, 
metastases from carcinomas of the breasts, kidneys, co lon, thyroid 
and esophagus may spread to the respiratory system and cause CAO. 
2.7 
CLINICAL MANIFESTATIONS AND DIAGNOSIS 
Clinical manifestations of malignant CAO depend on size, location , 
and the rate of progress ion of airway obstruction. Moreover, the 
patient 's underlying health status and ability to compensate for 
decreased airflow will influence the extent to which symptoms 
appear. 1·2 If encroachment into the airway is minor, then there wi ll be 
little impact on airflow and patients wi ll likely be asymptomatic and 
never brought to clinical attention . The majority of patients that 
experience symptoms of CAO have advanced disease and a hi story 
of underlying malignancy. 7•8 Thus, symptoms of CAO are late 
findings and include dyspnea, cough, wheezing, stridor and 
frequently, pneumonia .1.3·7 Because the e ymptoms overlap with 
those found in asthma and COPO, patients with malignant CAO are 
common ly misdiagnosed . However, a trong indi cation that 
symptoms are due to CAO is that they are unresponsive to inhaled 
steroids and bronchodialators . Other advanced CAO ymptoms are 
related to sign of decreased ventilation such as tachycardia, 
diaphore is and increased work of breathing.7•8 Symptoms of 
bradycardia, cyanosis and obtundation suggest that the airway lumen 
is severe ly compromised and in need of immediate interventi on in 
order to avoid imminent respiratory fa ilure.7 
Evaluation and diagnosi s of malignant airways is often based on 
clini ca l examinations as well as a tissue biopsy and radiological 
studi es to confirm the diagnosis 2 While chest radiographs have little 
di agnostic va lue, they may be used to quickly rule out other causes of 
breathing difficul ty such as tracheal deviations or a pneumothorax.2·3 
Che t and neck computed tomography (CT) scans make it possible to 
estimate tumour size, depth of in vasion, and the ability to see if the 
airway di stal to obstruction is still patent, providing important 
infonnati on for treatment planning.2.3 CT scans are typically always 
performed in conjunction with bronchoscopy, the go ld standard for 
eva luati ng CAO. Bronchoscopy allows for direct visualization of the 
tumour, eva luat ion of tumour length and locati on, differentiation 
between an intrinsic endobronchi al and ex trin ic tumours, and most 
importantly, is equipped to provide a tissue diagnosis 2 •3 Moreover, if 
needed, di agno tic bronchoscopy may be quickly converted to 
therapeutic bronchoscopy for CAO management. 
a b 
Figure 1: Schematic diagram of 1ntnnsic (a) and extrinsic (b) tumour 
obstruction of the central a11ways. Each demonstrates 50% occlusion. 
Adapted from BeDinger et al. Therapeutic bronchoscopy w fth immediate effect: 
laser, electrocautery, argon plasma coagulation and stents (2006) . 
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TREATMENT MODALITIES 
I) Therapeutic bronchoscopy: 
Therapeuti c bro nchosco py utili zes the ri g id sta inl ess s tee l 
bronchoscope to visualize, treat and debulk tumours. Its wider 
diameter facilitates ventilation allowing for a variety of procedures to 
be performed, including tumour debulking, laser resecti on, argon-
pia ma electrocoagulati on, ba lloon broncho copy, and stent insertion 
to re-cannuli e the airway2. 7, 
i) Tumour debulking: 
The harp bevelled tip of the ri g id bronchoscope is u ed to core out 
the tumour and apply pressure to a irway wa ll s promoting clot 
fom1ation. However, inadvertent damage to urrounding airways 
during treatment is a risk and complications may include cutt ing the 
lips, gum , larynx or a irway muco a or cartilage during intubati on. 
Perforati on o f the media tinum may also occur if the scope is not in 
line w ith the airway lumen8 
ii) Laser Resection: 
Laser energy de li vered by optical fibre is used to resect obstructing 
tumour . The main type of Ia er u ed during bronchoscopic resection 
is the eodynium :yttrium aluminum garnet (Nd:YAG) laser which 
transmit light energy at I ,064 nm wavelength to the ta rget tis ues 2 ,7 
The thermal energy from the Nd-YAG laser i absorbed into the core 
of ti sue where temperature may reach up to 100°C 2 The heat is 
then tran mitted and cattered around into surrounding tissues o that 
total ti ssue effects may extend up to I Omm below the surface o f laser 
admini strati on.2.7·8 Darker pigments, such as those found in blood 
max imall y absorb energy from Nd-YAG lasers. As a result, ti ssues 
ex posed to the laser energy are devascul ari zed- a process otherwi se 
known as e lectrocoagulation7 Additi onal admini strati on of the Nd-
YAG Ia er ca u es charring and eventual vapori zati on, which is 
removed by ventilation from the bronchoscope.2. If tissue is not 
compl etely vaporized, it may be mechani ca ll y debulked. Beca use 
tota l ti ssue e ffects are not immediately visible during treatment and 
may extend well past the depth of the tumour, compli cati ons include 
late devascularisation of adjacent healthy ti ssues well afte r the 
treatment i completed.2.s 
iii) Argon-Plasma Electrocoagulation: 
Argon-Plasma Electrocoagul ati on (A PE), as opposed to laser 
e lectrocoagulati on, i a form of non-contact e lectrocoagul ati on. 
s 111g a 5,000-6,000 vo lt park at the ti p of the probe, argon gas, a lso 
re lea ed at the ti p, become an ionized plasma that find the nearest 
grounded tissues produci ng coagul ati ve necros is.1 Advantage of 
A PC are that it may treat tumours latera l to or around a corner from 
the tip of the probe that would not otherw i e be access ibl e fo r laser 
therapy.1·9 T he e lectron energy utilized by A PC, however, doe not 
penetrate ti sue as deeply as Ia e r energy resulting onl y in 
uperfi c ia l necros is opposed to the deep ti ue necros i created by 
Nd-YAG laser .9 This may be des irable for treating superfi c ia l 
squamous ce ll carcinomas or if major blood vesse ls are c lose to the 
tumour bed.9 
iv) Balloon Bronchoplasty: 
Balloon bronchoplasty u es a ba ll oon to evenl y dil ate the a irway with 
m1mmal trauma and ub equent granul ati on tissue fonnation in 
mucosa l ti ssues. :While most ri g id bronchoscope techniques require 
general anae theti c, ba ll oon bronchoplasty may be perfonned with a 
fl ex 1bl e bronchoscope under consc ious sedati on.1 Dilation is 
immedi ately e ffecti ve and may be used for both intrin ic and 
extrin ic a irway ob truc.ti on . The re ults o f balloon bronchopla ty 
are ~o t typicall y su sta ~ned and dilation is usually followed by 
stent111g ?r laser resectiOn . ompli cation include airway rupture 
result111g 111 pneumothorax , medi astinitis and bl eeding. I 
v) Airway stent insertion: 
Airway stents are made of s ilicone, metal or a combination of both 
and are u ed to mechanically prop open obstructed airways. Stents 
restore airway patency, improve ventilation, and allow for the 
clearance of airway secretions.2•7·8 They can be used as standalone 
treatment or in conjunction with debulking and they do not interfere 
with ubse qu e nt radiation treatments , brachytherapy, or 
chemotherapy if any are needed.8 Moreover, if the patient's 
ventilation tatu improve following treatment, silicon stents can be 
removed.2 However, metal stents are very difficult to extract and are 
essentially permanent.2· s One of the greatest advantages to using 
tents is that they may counteract compression by tumours extrinsic 
to the a irway. Compli cati on include ste nt migration , more 
commonly een w ith ili con stents, and stent obstruction by recurrent 
tumour growth or granulation ti ssue formation (typica lly seen with 
metal stent ).2.8 ewer metal tents used for malignant airway 
obstruction have s ilicon covering and are made ofNitinol , a flexible 
e la ti c biomate ri a l, to help avo id stent obstruction .2 Additionally, 
newer silicone stent are meshed for fl exibili ty and haped or tudded 
to prevent tent migrati on2 
Indications fo r therapeutic bronchoscopy are the pre ence of 
ymptoms of advanced CAO. ecrosis, bleeding and cartilaginous 
destructi on are not contraindications for treatment. 8 In emergency 
settings, therapeutic broncho copy may provide more immediate 
improvement of the pati ent 's ventilator statu and tabili ze them 
enough for further treatment w ith radi ation or chemotherapy.s 
Drawbacks to the use of a rigid bronchoscope are that it require 
pati e nts to be under genera l anaes thetic . Thus, therapeutic 
bronchoscopy, balloon bronchoplasty withstanding, can only be used 
in patient that have enough remaining respiratory capacity to 
tolerate edati on. 
2) Radiation Treatment: 
Radiati on ha long been used to decrease tumour s ize and improve 
symptom th~ t result from a la rge tumour burden, espec ia lly in 
palli all ve settmgs. For malignant CAO, radiation may be delivered in 
one of two method : intrins ic rad iation treatment ( i.e. brachytherapy) 
or external bea m radiotherapy (E BRT). 
i) Brachytherapy: 
Brachytherapy re fer to the placement of a radiation ource within or 
adj acent to the ~i ue . be ing treated . Thi s is achieved by plac ing 
~adJat1on eeds d Jre.ctly mto the tumour ( interstitia l brachytherapy) or 
111 e~ling catheter 1nto the lumen of the organ be ing treated such a 
~n a1rway. For the treatment of malignant CAO, an empty catheter is 
1n erted 111to lumen o f the airway approx imately two centimetre 
beyond the e timated di ta l end o f a target area that includes the 
tumour.2 The catheter is then secured at the nostril and a radiation 
2 
~urce, most commonly iridiu~11 -l 92 , is then loaded into the catheter. 
· The area ta rgeted by ~ad1a tJ on can be several centimetre long 
depending on whether h1gh-do e radiation (HDR) or low-do e 
radiati.on (LOR) is u ed .2 However, LOR has fallen out of favour and 
HDR IS mo t c mmonly. used as it utilizes the greatest advantage of 
the brac.hytherapy tec.hn1que, ~h~t 1. , the radiation delivered directly 
at the 1te o f ta rget t1 . sues minimi zes radiation expo ure to nearby 
hea lthy organ otherw1 e ex posed during external beam radiotherapy. 
In th1 s way HDR brachytherapy exposes vital tructure near the 
airway- such a the esophagus, thyroid, mediastinum and aorta- to 
11111111nal ~mounts of radiation while enabling larger radiation do es 
to be deli vered to the target ti s ue ites A typ '1cal HDR · d 1· . · reg1men 
e Ivers a fraction dose of 7,000-8,000 cGy admini stered once a 
wee~ for three. week ; however, the exact dose and number of 
fractJ.ons (rad~at1on treatment ) will depend on the ize of the tumour 
and 1~s locat1on .2·8 Each fraction lasts between 3 to 30 minutes 
a llowmg brachytherapy to be delivered a 
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an outpati ent procedure. Brachytherapy is contraindicated for 
tumours that invade major arteries or other tructures within the 
medi astinum8 Compli cations include early and late radiation effects 
uch a radi at ion bronchitis, hemoptysis, bronchial stenosis, and 
bronchia l fistu las8 
ii) External beam radiotherapy: 
External beam radiotherapy (EBRT) has variable efficacy for treating 
CAO and the therapeutic effects may be quite delayed. However, 
EBRT continues to be a mainstay of treatment for CAO especia ll y in 
patients wi th hi ghl y advanced di sease or comorbiditi e that preclude 
them from undergoing general anaesthetic. Palliati ve doses of EBRT 
for the treatment of CAO are typica lly 3,000 cGy in I 0 consecuti ve 
fractions . Side-effects a lso include early and late radiation effects. 
Early effect are radiation dermatiti s to the overl ying skin and 
fatigue . Long-tenn effects mainly invo lve thoracic structures close to 
the airway ( uch as the lungs), whi ch may undergo fibrosis as a result 
of inadvertent radi ation exposure. However, current techniques in 
EBRT such as intensity-modulated radiation therapy in conj unction 
with shielding or stereotactic body radi otherapy effectively minimize 
radi ation exposure to surrounding ti ssue . 
3) Surgical resection: 
Surgical resection is usually reserved for tracheal tumours that have 
not yet metastasized to other areas of the body. If surgica l resection 
is successful at removing the entire tumour and achieving negati ve 
margins, it may be a curative treatment for cancer. The procedure 
involves removal of the tumour and the in volved trachea l segment 
followed by re-anastomosis or reconstruction of the trachea l tube.3 
Tumours that involve the carina or subglottic larynx can be 
successfully resected while preserving ventilation and voca l 
functioning .3 In addition, it is possible to remove up to 50% of the 
cervical or intrathoracic tracheal length without compromising 
anastomotic hea ling.2.3 While its advantage is that it is a potentially 
curative treatment fo r cancer, surgica l resecti on cann ot be 
performed if complete tumour removal threatens the hea ling of the 
anastomosis, if the tumour length exceeds 50% of the trachea or if 
vi tal structures such as the aorta or heart are involved.3 Moreover, 
the presence of CAO symptoms that alert clinicians to the need for 
treatment typica ll y appear at advanced stages of di sease when 
metastati c spread has likely to have already occurred . Although 
surgical resection cannot be performed after the mediastinum has 
received a hi gh-do e of radiat ion (due to impaired ti ssue healing), it 
may be followed by adjuvant radiation therapy to decrease the 
likelihood of loco-regional disease reoccurrence. 
DISCUSSION 
Interventions for mali gnant CAO are highl y technical and require a 
large amount of medi cal resources and teams of well-tra ined 
medical personneJ.2 Often the widespread avail ability of these 
treatments is limited to patients within a reasonable di stance of 
specialized center . However, many studi es have shown that these 
treatments are effecti ve, improve patient quality of life, and may be 
life-saving in emergent situations.3.4·5·6 In a prospecti ve cohort 
study of 20 patients with symptomatic CAO, a ll pati ent 
demonstrated improvements in airway diameter and 16 patients 
achieved greater than 80% patency using therapeutic bronchoscope 
techniques4 Moreover, the study demonstrated that Nd:YAG laser 
therapy alone, airway stenting alone, and a combination of stenting, 
laser, and/or cryotherapy were each indi vidually effecti ve at re-
establishing airway patency and improving symptoms.4 Similar 
positive results were demonstrated for the treatment of CAO using 
stent insertion and radiotherapy. Authors of a multi center tri al 
found that silicone mesh, studded stents re-established patency, and 
improved fun cti onal capacity, dyspnea, and g lobal functioning at I 
month and 3 months after stent placement. 5 HDR brachytherapy 
has also been fou nd to be successfu l in prospective cohort studi e 
at improvi ng symptom of CAO by more than 90%6 Lastly, for 
patients e lig ible fo r surgical resection, surgery offers a high rate of 
curative uccessJ Whil e most of these tri al compared intervention 
to no treatment and were not randomi zed control trials, they have 
demonstrated that interventi on may improve symptom and 
quali ty of li fe . However, to date there are no best practi ce 
guidelines avai lable on which interventi ons should be used. It has 
been frequentl y observed that the best approach includes a 
combinati on of treatment interventi ons2, and a lthough many centers 
are already uti li zing these interventions to manage malignant CAO, 
choice of treatment is heterogeneous and centre-speci fi c. 
As incidences of cancer and specifical ly bronchogeni c 
tumour continue to ri se, it can onl y be expected that a growi ng 
number of patients wi ll need to be managed for mali gnant CAO. 
Sign and symptoms of malignant CAO occur at advanced stages 
of disease and patients suffering from CAO almost a lways have a 
positive hi story for underlying ma li gnancy. Symptoms of CAO 
may be treated with a number of techniques including therapeuti c 
bronchoscopy, radi otherapy, or surgical resection . Each modality 
has been shown to improve symptomology, decrease morbidity, and 
improve quali ty of life. There are currentl y no best practice 
guidelines for managing ma li gnant CAO. While patient fac tors will 
contribute to the dec ision mak ing process, the cho ice of 
interventi on may be most determined by centre resources and 
ava ilabili ty of skilled personnel. 
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Hearing Aid: a new technology for single-sided 
deafness 
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H earing loss is a significant and common disabili ty that affects approx imately 9% of the Canadian population.' Thi s di sabili ty is more preva lent in older populations2 and if 
uncorrected can lead to soc ial iso lati on and communi cation 
difficulties2 ·3 There are two distinct types of hearing loss; each with 
a characteri stic pathophy io logy. Sensorineural hearing lo (SNHL) 
arises fro m conditions affecting the inner ear or the cochlear nerve, 
whereas conducti ve hearing lo s develops from conditi ons a ffecting 
the outer ear, the middle ear and the tympanic membrane. These 
di tincti ons are important since hearing aid technologies address the 
diffe rent types of hearing loss using different strategies . Patients 
with a conducti ve hearing los require the amplification of all sound 
wave frequencies. 2•3 In contrast, pati ents affected by sensorineural 
hearing loss present a much more complicated technological problem 
since these patients may have decreased audibility of certain sound 
frequencies as oppo ed to an overall decrease in the audibili ty of all 
sound frequencies 2 Most pati ents with sensorineural hearing loss 
have decreased audibility of hi gh frequencies;2 however, in the case 
o f Meniere 's di sease there is a decreased audibili ty of low 
frequencies.4 This results in the ability to hear sound but the inabili ty 
to understand speech since speech amplitude (loudness) is caused by 
low frequency sound waves which the patient can detect but speech 
comprehension is poor due to the loss in detection of the high 
frequency sound wave components.2 Speech comprehension is more 
diffi cult in the presence of background noi e and consequently 
hearing aid technologies address thi s issue by increas ing the signal-
to-noise rati o to bring out speech from no ise.2 
HEARING AID TECHNOLOG I ES FOR UN I LATERAL 
SENSORINEURAL HEARING LOSS 
Patients with unilateral sensorineural hea ring loss ( ingle-s ided 
deafness) also face difficulti es loca liz ing the direction o f unseen 
sounds and detecting sound loca li zing from the directi on of the 
affected ear, in addition to the difficulti es previously mentioned.s 
The head shadow effect cause a parti cular difficulty for these 
patients since sound waves orig inating fro m the affected ide are 
attenuated by the head before reaching the functional ea r. Several 
technologica l strategies used to address some of these problems 
include the routing of sound from the di sabled ear to the full y 
fun cti onal ear using air conduction contralateral routing of sound 
(C ROS) dev ices or bone-anchored hearing aids (BAHA).2.5 
While CROS devices do not allow for sound loca lizati on, they 
do aid a pati ent to overcome the head shadow effect. CRO devices 
consist of essenti ally two hearing aids. One hearing aid ac ts as a 
microphone in the affected ear and transmits the auditory ignal to a 
second hearing aid that acts as a receiver in the fun cti ona l ear. The 
CROS hearing aid in current use are wire less devices that u e FM or 
Bluetooth technology to transmit the auditory signal to the external 
rece iver.2 
BAHA devices take advantage of the physical property of bone 
to conduct ound . The first BAHA device was developed by a 
Swedi sh anatomist, Per-lngvar Branemark, and implanted in three 
pati ents in 1977. The dev ice has achieved international recognition 
as a solut ion to conducti ve hearing loss with more than 80 000 
device currently in use worldwide6 The device also has a second 
application fo r the treatment of unilatera l sensorineura l hearing loss.5 
The BAHA system consists of three components: a titanium post 
implant, an external abutment and an e lectronic sound processor. It 
is important to note that the BAHA ystem requires surgical 
implantation of the titanium post fo ll owed by the integration of the 
implant into the bony architecture. The device works by transmitting 
sound through bone to the inner ear thus, skipping both the external 
auditory canal and the middle ear.2·5 In the case of unil ateral 
sensorineural hearing loss the sound is transmitted transcranially and 
stimulates the cochlear fluid of the unaffected inner ear. The 
titanium screw is implanted directly into the masto id bone in order to 
overcome the lo s o f energy during the transcutaneous transmission 
of sound . The electronic sound processor is responsible for the 
transmi sion of ound vibrations via the externa l abutment to the 
titanium implant.7 Despite its value and populari ty, there are a 
number o f complications a sociated with the BAHA device. The 
most common complication is skin irritation at the site of the 
implant. 7•8 In most ca e , thi s can be managed using topical therapy. 
A more serious complication is the failure of the titanium post to 
osseointegrate.7•8 Thi complication can lead to poor function or 
failure of the implant. In addition, several less common but 
potentiall y dangerous compli cati ons such as kin flap necrosis, 
wound dehi scence, bleeding and pain have been reported8 The 
sound conducti on property of bone explo ited in the BAHA 
technology has also been applied in the most recent technological 
advancement for the treatment o f unilatera l sensorineural hearing 
lo ; the SoundBite Hearing Aid . 
THE SOUNDBITE HEARING AID 
A unique technologica l approach for the treatment of unilateral 
sen orineural hearing loss is the use of a removable ora l device 
called the SoundBite hearing system developed by Sonitus Medica l. 
The SoundBite hearing system also makes u e of the ound 
conduction properti es o f bone; yet, unlike the BAHA system does 
not require the use of surgery.3•9 The SoundBite hearing system uses 
a mi crophone unit housing a receiver and wire less transmitter to 
receive sound . The mi crophone portion of the unit its in the affected 
ear canal to take advantage of the ability of the ear 's pinna and 
ext~rnal ear canal to capture and direct sound into the microphone, 
whil e the rece1ver and the transmitter sit in a unit behind the affected 
ear
3
•
9 The unit then transmits the captured ound wirelessly to a 
10 UWOMJ I 80 :2 I Fall 2011 
removable oral device similar to a retainer that sits over the max illary 
molars in the mouth. The oral device touches several structures in 
the mouth including the gi ng iva, teeth and the inner cheek. The 
electrical signal from the behind the ear transmitter i captured by the 
ora l device and is transduced into vibrational energy usi ng a 
piezoelectric transducer.9 The vibration are conducted by way of the 
teeth to the bone and transcrani a lly to the cochlea of the ear. One of 
the advantage of the piezoe lectri c transd ucer is that it allows a much 
wider frequency range to be conducted through the teeth than the 
traditional e lectrodynami c transducers used in the BAHA systems.9 
The oral dev ice does not require the mod ifi cati on of the 
max illary molars and i custom fitted for each pati ent by taki ng a 
dental imprint of the max illary arch.3 Si nce the device vibrate the 
max illary molars to transmit v ibrat ions to the bone, the force of the 
ora l dev ice wa te ted to detem1ine if it wea rs the teeth . 
Interesting ly, the force of the oral dev ice is four orders of magnitude 
lower than the force exerted on the teeth by nonna l masti cation and 
is within the force range of nom1al orthodontic devices and does not 
damage the surface of the max ill ary molars.9 Moreover, the ora l 
device is comfortable, well to lerated in most pat ients, does not affect 
the speech and can even be worn whi le eating.3·9 There are several 
advantages of the SoundBite hearing system which are outlined in 
Box l . The most striking advantage of the SoundBite hearing sy tem 
when compared to bone anchored hearing aid (BAHA) i the 
avoidance of surgery9 A patient can be fitted qui ckly for the oral 
device and begin using the hearing aid immediately. With BAHA, 
surgery is required to imp lant a titanium post. The surgery is 
followed by 3 months of healing to ensure osseointegration of the 
implant before the pati ent can begin to use the device 2 The 
SoundBite hearing system avoids this delay and avoids potenti al 
surgical complications seen with the BAHA procedure. The 
SoundBite hear ing y tem is a tru ly unique and nove l technologica l 
approach to address unilateral sensorineural hearing loss. The next 
time you ee a patient with unil ateral sensorineural hearing loss, take 
a look in their mouth and chew on thi s possibility; they mi ght be 
li stening through their teeth! 
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Box 1: Advantages and Disadvantages of the Sound Bite 
Hearing System 
Advantages 
Avoidance of surgery and su rg ica l 
complications 
No need to wait 3 months befo re use since 
osseointegration is not required 
Discreet oral device and discreet behind the ear 
unit 
Optimized microphone location 
Del ivers high-fidelity sound w ith a w ide 
f requency range 
Removable devices 
Disadvantages 
Cannot drink alcohol wh ile wearing the oral 
device 
Risk of aspiration of the ora l device if the 
patient's physical responses are impaired 
Risk of swallowing the oral device if the 
patient's physical responses are impa ired 
Healthy teeth are needed to f it the device 
properly and good oral anatomy for full benefit; 
the last 3 teeth in the maxillary arch are usually 
the abutment teeth and must be free of active 
caries, periodontal and endodontic conditions 
References (3 ,9) 
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implantation issues in Canada and locally 
Niran Argintaru (Med icine 2014), Moska Hamidi (Medic ine 2013) and Laura Allen (Medicine 2013) 
Faculty Reviewer: Dr. Sumit K Agrawal MD 
I s de. afness a disease? Is it even a disability? Can or should it be "cured"? Such questions have been the root of many debates over the 
nature of deaf culture since the advent of cochlear implantati on in the 
late 1950s. As implants become more re liab le and provide increasing 
quality of hearing to profound ly deaf children and adults, many in the 
deaf community have grown to view implantation as a threat to both 
their way of life and the integrity of the communi ty. As a result, 
factions of deaf society have waged a war aga inst cochlear implants. 
" I would be remiss not to equate cochlear implants with genocide" 
stated a 1992 deaf position artic le.1 
While such quotations represent an extrem i t view in the 
communi ty, widespread concerns that cochlear imp lantation would 
diminish the deaf communi ty 's size and cohesiveness, and that 
cochlear implantati on represents a desire by the hearing population to 
"cure" deafness exi ted well into the 1990 .2 Many in the deaf 
community fear that cochl ear implants would result in decreased 
resource ava il ab il ty and accommodations for the deaf, and hence 
pose a threat to deaf culture. 
For the purpose of this artic le, deaf culture can be characterized 
as a communi ty largely composed of pro fo undly deaf indi viduals that 
views deafness as a difference rather than a disability2 They 
characteri ze lack of hearing as "deafhood" rather than "deafness", 
with some in the communi ty going as far as ca lling deafness a 
" birthright of si lence".3 This comm unity provides resources, 
ed ucation and training to its deaf members, a llowing them to 
function within the deaf community (i.e. through sign language) and 
in the hearing world (i.e . through lip read ing). If one were to consider 
implantation to be a treatment for profound deafness, most of those 
impl anted at a yo ung age are likely to not partake in the deaf 
communi ty as they would now be integrated into mainstream 
educati on.4 
As ev idence mounts in favour of cochlear implantat ion, a shift 
has been seen to a po int where th e vast majority o r e ligib le chi ldren 
are implanted, parti cularly if born to hearing parents. In response to 
the growing prevalence of implantati on, in 2007, the Canadi an 
Association of the Deaf (CAD) released a posit ion paper on cochlear 
implantation . They asserted that whi le the CA D has litt le concern 
about autonomous adult imp lantation, they do not believe emp iri ca l 
research has provided suffi c ient evidence for the effi cacy of cochlear 
implants in supporting first-language acqui s iti on in deaf chi ldren, 
who are unable to make the choice for themse lves.5 As the body of 
scientific literature in the field overwhelmingly supports early 
chi ldh ood imp lantat ion, the CAD 's pos iti on appears to focus on the 
right of every deaf child to learn sign language, regard less of whether 
they received an implant, a llowing them to grow up " bil ingual and 
bicultura l". It is diffi cult however to assert whether thi s po iti on 
refl ects an effort by the CAD to mitigate the loss of deaf cu lture by 
trying to increase the involvement of implanted children in the deaf 
communi ty. 
THE RI GHT TO CHOOSE: WHEN TO IMPLANT? 
With newborn hearing screening program offered in eight provinces 
and three territo ri es as of 2008 , children with s ignificant hearing 
deficiencies are identifi ed earlier than ever6 Therefore, armed with 
an early diagnosis , parents are dri ven to make a decision regarding 
cochlear implantation in e ligible children earlier in the child 's life, 
with an increasing body of evidence indicating s ignificant advantages 
to earl y implantation . otably, implantation in children under two 
year o ld has been extensive ly shown to provide s ignificant 
improvement in language perception and vocabul ary, often allowing 
recipients to enter first grade wi th language ski ll s comparable to 
children with normal hearing.7.8 Recent evidence indi cating that 
implantat ion as early as ix month old lead to better long-term 
improvements in language, socia l ski ll development and s ignificant 
advantages in parent-child bonding, has resulted in some centres 
implanting infa nts even earlier.9 While the current guidelines advise 
imp lantat ion at around two years old, studi es have shown little 
additiona l ri sk of implanting patients at a significantly younger age, 
hence further shi ft ing the trend towards earli er implantation. 
Is thi s trend towards early imp lantati on signifi cant in tenns of 
informed con ent? The main decision to implant has shifted away 
fro m the patient when early chi ldhood implantation tarted becoming 
common. This has left parents w ith the full responsibil ity of choosing 
implantation as well as the degree of deaf education the child will 
receive if implanted . However, with children implanted earl ier, 
parents are faced with shorter timelines during which to educate 
themse lves about the procedure. Therefore, while implanting at six 
months versus two years does not s ignificant ly a lte r the child 's 
abi li ty to contribute to the decision, it may decrease the amount of 
time the parents have to con ider the choice and could arguably 
pre ure parents into rash decisions. 
FUNDI NG OF COC HLEAR IMPLANTS lN ADULTS AND 
PEDIATRIC POPULATIONS 
Current ly, three .centers (Toronto, London and Ottawa) provide the 
over 190 cochlear implant surgeries performed annua lly in Ontario. 
With wait times for imp lantation surgery fa r above the recommended 
three months for pediatric popu lation and six months for adults 10 
the Ontario government re leased an additiona l $5.9 mi ll ion i i~ 
fun?ing in .March ~0 11 to cut wait times in ha lf. 11 Unfortunate ly, it is 
unlike ly thi s one-time fu nding package w ill address wai tl ist is ues in 
the long-run, particul arly in the time-sensitive implantation of 
chi ldren as discussed above. 
Specifica lly in London, a s ingle annual budget is provided for 
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both pediatric and adult implantations. There are several problems 
that arise from this funding mode l. Firstl y, as implant costs are 
covered under provinc ial hea lth funding, patients cannot purchase 
their own implants in accordance with the Canada Health Act. 
Secondly, since a lump sum is all ocated to the fundin g of implants 
per hospita l, implantati on can be undertaken only until the sum is 
ex hausted in a g iven fi sca l year. La tl y, due to the ev idence presented 
above for ea rly pediatric implantation, in fants must be implanted 
with in a certai n window of time after the di agnos is. Therefore, as 
more pediatric implants are perfo rmed, adult patient are pushed 
back on the wai t-li st fo r their implants. However, this funding mode l 
does empower the hea lthcare prov ider in the audi ology tea m to 
eva luate patients and ass ign the funding to those they determine 
require it most. 
UNILATERAL VS BILATERAL IMPLATATION 
The Canadian Association of Speech-Language Pathologi ts and 
Aud iologist (CASLPA) publi shed their official posi tion in the 
Journal of Otolaryngo logy supporting bilateral cochl ear implantati on 
in all e li gib le children. Bilateral implantat ions prov ide advantages in 
sound loca liza ti on, speech isolat ion in no isy conditions and improved 
deve lopment of the auditory system with few additional ri sks. 
Additi ona lly, by implanting both ears, the " better ear" (the ear that 
w ill fu ncti on better with the implant) is always impl anted , 
maximi zing benefits fo r the pati ent. 12 Hence, fo r the most part, 
e ligible Canadi an children who rece ive implantation undergo 
simultaneous bi lateral implantation as studies have shown no 
advantage to implanti ng the second ear on a later date, particul arly at 
an older age.13 
While pedi atric implantati on has been shown to be cost effecti ve 
by several tudies 14, the cost effecti veness of providing bilatera l 
implantation has been questioned due to the use of publi c fundin g of 
the implants. A systemic review done in the United Kingdom 
comprised of 33 trials, including two randomized control tr ials 
showed a fa r higher cost effective quali ty-adj usted li fe-year returns 
fo r unilateral implantation versus the bilateral implantation in 
pediatric and adult populati ons. 15 With mounting evidence and strong 
recommendat ions in favour of bilatera l implantation, why is the cost 
effecti veness of the second implant much lower than that of the first? 
Firstly, the quali ty of li fe measures used to gauge improvements 
fo llowing the second implant are much more uncerta in and 
inaccurate, as Bond 's 2009 rev iew acknowledgesl 5 For example, it is 
difficult to measure the improvement in quality of li fe ga ined fro m 
increased abi li ty to loca lize sound or isolate speech. Secondly, with 
the abili ty of a unilateral implant to allow children to attend 
mainstream school and often requ iring almost no specifi c educational 
assistance, the majori ty of savings are rea li zed with the first implant 
and are hence not refl ected in the additi on of a second implant. Most 
significantly, the incremental improvement from having nearl y no 
hearing to considerable hearing achi eved with a unilatera l implant is 
bound to be considerably higher than the improvement achieved with 
the second implant. 
CONCLUSIONS 
By many accounts, those who argue that cochl ear implantati on is 
unethical , ineffecti ve or simpl y not the best choice for profoundl y 
deaf children appear to have been unsuccessful in preventing their 
widespread use. However, as implantation shifts fro m being a 
novelty to the norm, the issues of fundin g and cost efficiency appear 
to have taken centre stage in Canada, and particul arl y in Ontario. 
With early bilateral implantation established as the best therapy for 
profoundl y deaf children, funding must be available to implant a ll 
eligible children whose parents choose implantation. If such funding 
is not available, as seen in some centres, wait lists will persist and 
grow particularly in adults as pediatric pati ents are g iven priori ty. 
Desp ite the effectiveness of imp lants, it is important not to di count 
the services and supports the deaf commu nity provides to its 
members. Imp lantat ion i not a cure; rather, it i a upport ive 
treatment tha t along with considerable training allows for increased 
fu nct ioning. Therefore, those implanted may sti ll find they can 
benefit fro m partici pat ion in the deaf co mmuni ty through support and 
sign language trai ning. 
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0 ur face allows us to convey our every thought and feeling with those around us in a nearly instantaneous manner. Without our face, we would be stuck in an emot ion less and 
depre si ng se lf-ex istence devo id of a prima ry ve hi c le of 
com munication. As soc ial beings, it is in our very nature to share our 
expre ion with the out ide world . It i likewise in our nature to 
subconsciously j udge each face, ass igning certai n traits to parti cular 
facial characteri tics. One of the most important characteri stics that 
we judge is "beauty". Interestingly, there is an unusually consistent 
agreement of what is con idered "beautiful " amongst different 
cultures, but onl y when we are referring to the face rather than the 
body, a topic that wi ll be ex plored herein . 
BEAUTY OF THE BODY 
So what is it that makes a person "beautiful"? Beauty is an arbitrary 
and abst ract concept that is seemingly difficu lt, if not impossibl e to 
define. Considering the vast di versity in thi s world and the countless 
cultures it conta ins, one would expect that surely there must be 
di ffe rent culturally dependent standards of beauty. However, research 
suggests that this is onl y parti ally correct. 
Research examining the physica l attracti veness of the fema le 
body often uses the wa ist-to-hip rati o (WHR) as a quantifiabl e 
measure. Indeed, studies have found that males from most cultures 
and across history strongly prefer female figures with a low WHR., ln 
the developed world, hea lthy females have hi gher leve ls of estrogen 
that cause more fat to be deposited on the buttocks and hips rather 
than on the wa ist, leading to a low WHR.Thus, the WHR is an 
indicator of health status and ferti li ty, and male pre ference for low-
WHR females is considered an excell ent exampl e o f ma le assessment 
of mate quality3 
Despite the overall preference of men for women with a low 
WHR, variations do ex ist, thereby casting doubt on the theory that 
thi s may be a uni versal idea l. Another measure of body habitus is the 
body mass index (BM !), whi ch is a heuri stic proxy for human body 
fat. Different cultures and populati ons prefer females of different 
BMI and WHR due to different sociocultura l influence . Undeniably, 
the effect of " Westerni za ti on" may be contributing to a more 
universal standard o f bea uty, but thi is not due to our innate 
evolutionary preferences. Regardless of these influences, a study 
comparing fema le phy ica l attracti vene between Japanese and 
British participants found that Japanese men preferred images of 
woman with signifi cantl y lower BM!s than Britons and likewi e 
were mo re re li a nt on body shape when judging ph y ica l 
attractiveness. 
However, the fl aw with these studi es in general is that every 
culture tested so far has been ex posed to the potentially confounding 
influence of Western media . A landmark study by Yu and Shepard 
assessed the WHR preferences of a culturally iso lated population of 
Matsigenka indigenous people in Peru, who are located in an 
exten ive nature park where access is restricted solely to scientific 
and offic ial visitors and the vast majori ty of natives have never left 
the premises .3Their results showed that the WHR preferences of 
males of thi s tribe di ffe red strikingly from those of the United States 
control population as well a from other world culture , with the 
"over-weight" female ranking highest in the factors of attractiveness, 
hea lthiness, and preferred pouse.3 
The e were critical finding a they di ffe red striking ly from the 
pre ferences of ma les in other cultures. The authors suggest that this 
difference may be due to the fact that in traditiona l societies, physical 
featu res may play a lesser role because mate choice is limited by 
kinship rul es, and potenti al mate have access to direct info rmation 
about mate quali ty, such as age and history of illness.As a result, they 
do not rely primarily on information inferred from physica l 
appearance . In contrast, in industrialized societi es, daily ex posure to 
strangers from an early age may increa e the importance of u ing 
physica l featu res to assess potential mates based on these factors .3 
FACIAL BEAUTY 
It seems reasonable to que tion > hether the e relative cultural norms 
likewi e influence our perception of facial beauty.Counterintuitively, 
the answer is no. Be fore ex ploring thi s topi c, we must first consider 
what exactly facia l beauty is and how to define it. The quest to find 
to suitable defi nition of fac ial beauty date back to antiquity, when 
the ancient Greeks be lieved that beauty appeared when the ratio of 
many di ffe rent facial features to each other approached the value 
I : 1.6 18, the o ca lled golden ratio. However, things are not so 
simple, as further research has shown that facia l beauty i more a 
combination of symmetry and an idea l harn1ony of the facia l features 
with each other. And mo t importantl y, as humans we have an innate 
mechani sm for detecting this elusive concept of beauty. 
Symmetry is an important a pect of facia l beauty and i tied to 
evo lutionary fitn ess, where le ft-ri ght bilateral symmetry describes 
hea lth and hi gh genetic quality, and devi ations from it may indicate 
poor qualities and there fore form a basis for rej ection of a potential 
mate., 
.There are several exa mple that seem to re inforce this concept. 
For Instance, supermodels, arguab ly con idered the mo t attractive 
members of We tern ociety, have the least degree of facial 
asymmetry when compared to the general population. Facial 
a ymmetry ex ists a long a gradient in our population and it is clear 
that we have evo lved to tolerate some degree of thi asymmetry. 
Interesting ! ~, studi es ha~e shown that averag ing a random group 
of. faces results 111 a synthet1c face more attracti ve than any of the 
ong mal faces .,The faces used in these ana lyses consisted of thirty-
two completely random faces from a pool of different cul ture , yet 
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observers always ranked the composite face as be ing the most 
attractive. Paradox ica ll y, th i suggest that the ideal ham1ony of the 
fac ial featu res that we consider to be "beautiful " is actua lly as close 
to "average" as pos ible. Naturall y, such statements have drawn 
criticism from many indi vidua ls who refu se to be li eve that beauty 
may in any way related to "averageness". 
It is critical to note that the com putationa l "average" of fac ial 
features that is considered attract ive in thi s case is completely disti nct 
fro m what cul ture commonl y refers to as an "average" fa ce, whi ch 
natura ll y has a nega ti ve connotati on and is not conside red 
"beautiful ". There are certa inly unique and interesting fea tures that 
may add to the perce ived attract iveness of an indi vidua l's face, but it 
is important to realize that they must be associated with an "average" 
face and must be harmonious with the other faci al fea tures. 
There have bee n a rguments th at bea uty is a cul tura l 
phenomenon engrained in us repeatedl y th roughout our youth, 
resul ting in a bia ed preference such as that of male for females with 
a low WHR ratio . However, there are many examples that d isprove 
this theory. Eleven separate meta-ana lyse have revea led very hi gh 
agreement in fac ial-attracti veness ratings by raters both within their 
own cul ture, and across other culture ., In fact, the effect sizes were 
more than double the size necessary to be considered large and 
thereby strongly suggest a uni versal standard by whi ch fac ial 
attractiveness is j udged. 
ln order to negate the possible influence of Western media, a study 
examin ing preferences fo r fac ia l symmetry between Briti sh 
individuals and the Hazda, a hunter-gatherer soc iety of Tanzania, 
likewise found that facia l symmetry was more attracti ve than 
asymmetry across both cultures.These findings fu rther question the 
assumpti on that ratings of facial attracti veness and ideals of fac ial 
" beauty" are culturally unique and are consistent with the fac t that 
young infa nts prefer to look at face that adults likewi e consider to 
be attractive. 
It is important to realize that there are exogenous fac tors that 
augment attractiveness and beauty as it pertains to mate selection, 
whi ch is prec isely why it i such an elusive concept to define. Dutton 
argues that based on Darw inian aestheti cs, indi vidua ls consciously 
select mates who have certa in characteristics, and that such 
characteri stics in fac t may make the person more attracti ve and 
"beautiful " to them. Dutton further states that it is human personali ty 
that adds another dimension of beauty, with traits such as a delightful 
sense of humor and generosity being attract ive. !? Although it is still 
evolutionarily based on fi nding a healthy mate who is able to provide 
care, it is thi s rationa l intention combined with physica l appearance 
that forms a complete view of beauty and attractiveness. 
CONCLUSION 
Beauty is an elusive concept that is envied and sought by many, yet is 
extremely difficult to defin e.Aithough the beauty of the body has an 
evolutionary basis, the concept of the ideal body is a cultural 
construct that has been influenced and continues to be influenced by 
culture and media. Conversely, fac ial beauty is a biologicall y 
ingrained concept based on symmetry and an idea l coalescence of 
that fac ial features with each other that transcend barri ers of culture, 
media, and time. Ultimately, concepts of beauty and attracti veness 
are evoluti onarily based, but cannot be looked at narrowly as based 
so lely on appearance as they are augmented by exogenous fac tors. 
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Incidence of acute respiratory distress 
syndrome and acute lung injury in patients 
requiring prolonged mechanical ventilation 
Paul Kudlow, B.Sc. (Meds 2013), Chu L, B.Sc, Herridge MS, M .D., M.P.H 
Faculty Reviewer: Nigel Paterson, M .D. 
P rimaril y affect ing critical care pati ents, Acute Lung Injury (ALI) and its more severe variant, Acute Respiratory Distress Syndrome (A RDS) are devastating clini ca l syndromes, 
h av in g lo n g- te rm functional a nd neurop syc hol og ica l 
conseq uences I ,2,3. Further characterized by acute hypoxemia, 
bilateral pulmonary infiltrates on frontal chest radiography, and no 
clinical evidence of left atria l hypertension, AR.DS/ ALl are severe 
inflammatory conditions of the lung parenchyma4 ,5. The resulting 
severe hypoxemia combined with the exten sive release of systemic 
inflammatory mediators often leads to multiple organ failure; 
responsible for high rates of morbidity and mortality in the 
populati on6. Despite many recent advances in our understanding of 
the pathophysio logy, treatment, and long-term outcomes of ARDS/ 
ALI , in cidence and preva lence of these conditions remains 
uncertai n6. The uncertainty in tum reflects the heterogeneity of the 
syndromes, the lack of de finitions for the underlying disease 
processes, and fa ilure to uniformly define the population within 
which pati ents wi th ARDS/ALI are identified5 . The incidence of 
ARDS/A LI in the United States has been estimated to be around 
300,000 ca es per year, but thi s may be an underestimate6. A recent 
study, conducted by Rubenfeld et al. examined the general ICU 
population and found the incidence of ARDS/ ALI to be somewhat 
hi gher, at approxi mately 58.7 and 78.9 per 100,000 respectively; 
giving an annual estimated incidence at around 141 ,500 and 190,600 
cases of ARDS/A LI respecti ve ly in the United States per year6. 
The purpo e of the current study was to determine the incidence 
of ARDS/ALI in a pilot sample from a prospecti ve multi -centre 
follow-up of critica lly ill patients mechanica ll y ventil ated for at lea t 
one week - the Towards RECOVE R study? . The incidence of A RDS/ 
A Ll in patients requiring pro longed mechanica l ventilati on is not 
known. We hypothes ized that the incidence of AR.DS/ALI would 
exceed that found in general ICU pati ents, as cited above. 
METHODS 
As part of the Towards RECOVER study protocol?, pati ents were 
included if they were ~ 16 year o f age and mechani ca lly ventil ated 
for at least one week . (n= 82) . Chest imaging was performed dai ly 
for the first ICU week and each Monday and Thursday therea fter. 
investigators (PK, LC) underwent systemati c training on Chest X-
Ray (CXR) interpretation for ARDS/ ALl by a standardi zed on line 
educational tutoria lS. CXRs were divided into 4 quadrants, each 
ana lyzed for the pre ence or absence of bi lateral infiltrates consistent 
with non-cardi ogenic pulmonary edema. Diagnosis of ARDS/ALl 
was based on American Europea n Consensus Conference on AR.DS 
(AECC) guidelines. Data was analyzed to detennine the percentage 
o f radiograph read independently as ARDS/ ALI by each reader and 
interobserver variability was be calcu lated (kappa-stat istic)9. All 
analyses were performed using appropriate so ftware. 
RESULTS 
The study sample contai ned 82 pat ients . They had a median age 59 
year , the male : female rati o was 1.4:1, and 45% of those sampled 
were found to have ~ 2 comorbidities. The median APACHE II core 
of wa 25 and a the median ICU LOS of was 37 days. In our study 
sample, 72% survived until ICU di charge. 
To date, the records of 25/82 pati ents have been examined (by both 
co-authors) for the presence of ARDS/ALI. Of this sample, 2 1/25 
(84%) had radi ographic ev idence of bilateral infiltrates and fulfilled 
AECC criteri a for AR.DS/ALI. Interobserver variability, measured by 
kappa score, was 0.60 (Figure I). 
DISCUSSION 
In thi s limited ample, there were a high proportion of patients who 
fulfilled the criteria for ARDS/ALI. Although there was insufficient 
data to accurat ly calculate incidence at present, our preliminary 
proporti on of 84%, ugge t that the incidence of ARDS/ALI in tho e 
mechanica lly ventilated for at least I week, likely exceeds 58.7 and 
78.9 per I 00,000 per on-years respecti vely as previou ly de cribed 
by Rubenfe ld et a l. in their ampl e of general ICU patients6. Our 
result were trengthened by relatively good agreement between 
independent e aluators; we measured a kappa score of 0.60 (Figure 
I ). 
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Figure I. The area of the circ les is proportiona l to the number of 
subject given a particu lar pair of ratings. 
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Taken together, our preliminary result sugge t that ARDS/ALI are 
likely under recognized conditi ons, particul arly in cri tically ill 
patients requiring prolonged mechani ca l ventilation. Earlier tudies 
have estimated the mortali ty due to A RD I ALl at around 133,500 
deaths per year in the Uni ted State 6. Given the possible under 
recognition however, ARDS/ ALI are conditi ons likely responsible 
fo r even more deaths in the population. Besides mortali ty, ARDS/ 
ALI also leads to large amounts of costly and often debi litating 
morb idity in urviving pati ents and their caregiver I ,3,6. Outcome 
studi es have consi te ntl y fo und s igni ficant functi ona l and 
neuropsychological derangement at both I year and 5 years po t 
illness \ ,2,3. Perhaps better identification of AR.DS/ALJ in the fi r t 
place may help to more efficiently a llocate hea lth care resources - in 
tum potentia lly preventing orne of the typica l long-term sequelae 
currently experi enced by survivors and their caregivers. 
Before making any fi rm conclusions however, it should be noted 
that a lthough the results of our preliminaty study are suggesti ve of 
under recogni tion of AR.DS/ALI, they are subject to a number of 
important limitations. Particularl y, thi s study wa not only limited by 
ample ize, but a lso, data coll ected was subj ect to survi vorship, 
selection, and ascertainment biases. Additi onall y, analysi of data 
collected was limited by the level of training of the independent 
evaluator (PK, LC). The independent evaluators were tra ined using 
an online standardized tu torial to a sist in the detennination of 
bilateral pulmonary infi ltrates as per AECC guideline 5,8. Although 
good agreement was measured benveen independent evaluators, the 
data remain to be fo rmall y evaluated by a trained phy ician. 
Therefore, larger fu ture studies are needed to va lidate and confi m1 
the preliminary re ult of thi current tudy. 
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Shortness of breath in a 12 year-old boy: a 
classic presentation of stage IV Hodgkin's 
Disease? 
Michael Livingston (Meds 2011) 
Faculty Reviewer: Dr. Neil Merritt, M.D., FRCSC 
S hane is a 12 year-o ld boy who presents to your offi ce with worsening shortness of breath on exerti on. Hi s fa ther ex plains that hi s son had severe asthma when he was younger. He wa 
adm itted to hospital when he was 2 years old and put on a vent ilator 
in the intensive care un it when he was 4. Hi s symptoms have been 
much better since then. In fac t, Shane hasn't had to use puffers very 
much at a ll up until a few month ago. He started u ing Yentoli n 
again while playi ng soccer and does get some relief with thi s. 
IS IT ASTHMA? 
You take a thorough history from Shane 's father. He notes that the 
shortness of breath has come on gradually over the last few months 
to the point where it causes Shane diffi culties several times per week. 
There is no hi story of producti ve cough, and no fever, night sweats or 
weight loss. Shane has no other medi cal conditi ons, no known 
allergies, no previous surgeries, and his vaccinations are up to date. 
Hi parent are from Barbados but he ha never been out of the 
country himself. Shane 's 13 year-old brother had a cough recentl y 
but there are no other sick contacts. 
On examinat ion, Shane is a lean-looking child but otherwise 
appears well. Head circumference and height are above the 50th 
percentile and weight is above the 25th percentile. He has no 
cerv ica l, suprac lav icul ar, infrac lav icul ar, ax ill ary, or inguina l 
lymphadenopathy. His respiratory exam is significant for mild 
wheeze throughout but no crackl es or areas of decreased breath 
sounds. 
You explain th at Sbane's symptoms most like ly repre ent 
worsening asthma. You give Shane a prescription for inhaled steroid 
and encourage him to use it tw ice per day. You also give him a re fill 
for Vento! in and explain that he can use it whenever he fee ls short o f 
breath . Shane's father agrees to foll ow-up with you in one month . 
IS IT INFECTIO US? 
You see Shane and hi s father back in clinic one month later. Hi s 
father looks very concerned. The hortness o f breath co ntinues to be 
an issue and now Shane has a rash. The rash sta rted behind hi s knees 
and has spread to hi s trunk, arms, and neck. The rash is pruritic and 
bothers Shane quite regularly. 
You do a full review o f systems and di scover than Shane has 
been feeling generall y un we ll recentl y. He reports no night weats, 
fever, or weight loss, and no pain at night. Examinati on o f the rash 
revea ls numerous crusted papu les measuring 3-5 mm in diameter 
(see Figure I). Hi s father assures you that Shane has already had 
chi cken pox. The phys ical examinati on is otherwi se the same as 
Shane 's prev ious visit. There is no lymphadenopathy and the mild 
wheeze heard on respiratory exam is unchanged. You prescribe 
hydrocorti sone cream for the rash and set up an outpati ent re ferral to 
In fec ti ous Disease. 
Figure 1. Crusted papules measuring 3-5 mm consistent with 
pityriasis lichonoides [ 4). 
WHAT ELSE CO LD IT BE? 
hane is seen by your co lleague in Infectious Di ease six weeks later. 
hane has now deve loped a dry cough. The rash is till present 
although the itchine s i re lieved so mew hat by the topi cal 
hydrocorti sone. A rev iew o f systems reveal s that Shane has now lost 
about 5 pound since the worsening of shortness of breath began . 
hane deni es feve rs and night sweats, but hi s father ays that, "he's 
been feeling rea ll y unwell recentl y." Physical examination reveals 
anteri or cervica l and supraclavicular lymphadenoapthy. The nodes 
are nontender, rubbery and range in size from 1 to 2.5 em. 
Respiratory exam is s ignificant for wheeze but there are no crackles 
or areas o f decreased breath sounds. 
Your colleague ex plains that he needs to get a chest x-ray as part 
of hi s workup . He agrees that Shane is quite sick and will need more 
te ts. He sends Shane to the Pediatric Emergency Department for 
furth er eva luation . 
HOW BAD IS IT? 
Shane is as essed in the Emergency Department later that afternoon . 
He has a fever of 38 .5 degrees Celsius, tachycardia with a heart rate 
o f I ~5 ~ and oxygen saturation of 94% on room air. The Emergency 
Phys1c1an orders a chest x-ray (see Figure 2) and bloodwork. The 
chest x-ray reveals mass- like pulmonary opac ities in both lungs and 
enlargement o f the hila and superior medi astinum . 
B loodwork is s ignifi cant for a white b lood cell count of 32.0 
~hich con ist o f 24.0 neutrophil s and 4 .1 eosinophil s. Hemoglobi~ 
IS decreased s lightl y at 129. Platelets are elevated at 55 1 C reacti ve 
protein is 111 .8, and erythrocyte sedimentation rate i '54. Lactate 
dehydrogenase is high at 61 6 but urate and calc ium are normal. 
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Figure 2. Chest x-ray of a 12 year-o ld boy, howing a medi a tina] 
mass, hil ar enlargement, and patchy mass- like opacit ies in the lungs. 
Shane is admitted to hospital by the inpatient Ped iatrics team for 
further workup. The differentia l includes infection, va culiti , and 
ma li gnancy. He is placed on airborne contact precauti ons and 
admitted to a negati ve pres ure room until tubercu losis can be rul ed 
out. 
IS IT CANCER? 
Shane undergoe a CT scan of the pelvis, abdomen and thorax the 
following day (see Figure 3). The CT revea ls multiple solid nodules 
in both lungs, as well as mediastinal and hil ar lymphadenopathy. 
Enlarged nodes are seen in the para-aortic area but there are no signs 
of a primary tumor. 
General urgery in consulted to obta in a biopsy. Shane and hi s 
parents remai n anxious over the next few days as they wa it for a spot 
to open up in the operating room. In the meantime, Shane's white 
blood cell count remains in the hi gh 20s and plate lets rise up to 762 . 
Shane goes to the operating room three days after hi s admission for 
biopsy of a superficial supraclavicular lymph node and skin under 
genera l anesthetic. Frozen section of the lymph node is pos iti ve for 
malignancy but fl ow cytometry is normal. A definite diagnosis is 
deferred until permanent sections can be processed. 
Over the next few days, Shane's shortness of breath worsens. 
The vasculitic bloodwork comes back normal and acid-fast cultures 
are negati ve for tuberculos is. The fina l pathology report i relea ed 
one week later indicating Hodgkin 's Disease, Nodular Scleros ing 
subtype. 
IS TIDS STORY TYPICAL FOR HODGKJN'S DISEASE? 
Shane's story may seem somewhat convo luted but hi s symptoms are 
actually quite typical. In children, less than 20% of patients present 
with one of the classic "B" symptoms of Hodgkin 's Disease (weight 
loss, fevers, and drenching night sweats) [ 1] . In fact, the most 
common presentation in children consists of painless cervical 
lymphadenopathy (which occurs in 70-80% of cases) and/or a 
mediastinal mass (in 50% of cases) [2] . Shane's initial chief 
complaint was shortness of breath due to the mass effect of 
mediastinal lymphadenopathy. This eventual ly progressed to a cough 
and hypoxia. The lesions in the lungs represent a combination of 
Figure 3. Computed tomography scan of the thorax showing masses 
in the lungs and hil ar and medi stinallymphadenopathy. 
contiguous spread from hilar lymphadenopathy and metastases to 
lung parenchyma [3]. 
The rash and itchiness that Shane ex perienced isn' t that unusual 
either. In fact , some patients will give a hi story of insid ious itchiness 
for months before being diagnosed wi th Hodgkin 's Disease [2] . The 
sk in les ions in thi s case most li ke ly represented pityriasis 
lichenoide , which is a sociated with lymphoma [4]. 
Shane 's initial blood work is classic fo r Hodgki n 's Disease. At 
first glance, the elevated white blood ce ll count consisting almost 
entirely of neutrophil s would seem to suggest an infectious etio logy. 
This is certa inly supported by the hi gh platelet count, C reacti ve 
protein, and erythrocyte sedimentati on rate. (Indeed, in this case, 
Shane remai ned on airborne contact precauti ons until tubercul osis 
was fonnall y ruled out with a negative acid- fast bacilli culture.) 
Neverthe less, a complete blood count characteri zed by neutrophilia, 
eo inophili a and thrombocytos is is cia sic for Hodgkin 's Disease in 
children, and is not due to underl ying in fec ti on [I , 2, 5]. 
The presence of elevated lactate dehydrogenase would lead to 
some suspect tumor lysis syndrome. The elevated levels seen in thi s 
case ac tuall y represent a hemolytic anemia, which is not uncommon 
in Hodgkin 's Disease [6]. The normal serum electrolytes and urate 
leve ls seen here stand aga inst the presence of ongoing tumor lysis. 
WHAT lS THE PROGNOS IS? 
Shane has stage NB Hodkin 's Disease according to the Ann Arbor 
Staging Class ificati on [5]. He has diffuse invo lvement of I or more 
extral ymphati c organs (stage IV) and has 8 symptoms (B). This 
places Shane in the hi gh-ri sk category [5, 7]. Even so, with proper 
treatment and monitoring the 5-year survi va l for children like Shane 
is up to 90% [7 , 8]. Shane was started on induction therapy whil e in 
hospita l, consisting of cyc lophosphamide, vincri stine (Oncovin), 
procarbazine, and prednisone (COPP). He was di scharged home once 
hi s breathing improved and will complete three more courses of 
treatment before rece iving radiati on therapy. 
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Obstructive sleep apnea in children: the when, 
how and why of screening 
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0 bstructive sleep apnea syndrome (OSAS) is part of the spectrum of sleep disordered breathing (SOB) and is estimated to occur in about 2% of the pediatric population ,1 
whereas 2-5% of adults are affected 2 The peak incidence of OSAS is 
in pre-schoo lers, when ton illar hypertrophy i most common .3 Like 
adu lt OSAS, pediatric OSAS is caused by periods of complete or 
partial upper airway collap e during leep, disrupting nonnal sleep 
patterns and resu lting in intennittent hypoxia during apne ic and 
hypopneic episodes. It i believed that OSAS results from a 
combination of anatomic abnormalities resulting in decreased space 
and increased pressure in the upper airway, and neuromuscular or 
funct ional abnorma lities that cause decreased muscle tone wh il e 
sleeping and lead to periodic a irway co ll apse.3•4 
There is an increas ing awarene s about the preva lence and 
consequences of OSAS in the adult population among primary care 
physic ians, a llowing for improved screeni ng, diagnosis and 
treatment. 5 However, the recognition of thi s disorder in the ped iatric 
population is much more difficult, and current screening among 
primary care physicians is inadequate 6 Children with OSAS present 
with different symptoms, have different ri sk factors , different 
pathophysio logy, and require different management strategies than in 
adults.4•5.7 
CLINICAL IMPORTANCE 
OSAS in chi ldren has been shown to contribute significantly to 
childhood morbidity with consequences seen in multiple systems.The 
severity of sleep apnea has a dose-dependent re lationship with 
decreased left ventricular function leading to congestive heart failu re 
and cor pulmonale. 1 Plasma C-reactive protein level , a marker of 
inflammation with an important ro le in atherogenesis, have a lso been 
shown to be elevated in children with SDB,8 and fasting in ulin 
levels a lso seem to correlate with the disease severi ty, independent of 
BMJ.9 Failure to thrive and a low weight index have been noted in 
children with OSAS, possibly due to changes in hormonal release 
during apneic episodes. 1o 
It is known that OSAS in adu lts resu lts m daytime 
hypersornnolence and psychological seque lae such as di sturbed 
concentrat ion and memory,2 however in ch ildren the deficits in 
neuropsychologica l and behavioural functioning caused by untreated 
OSAS can severely affect development, interfere with learning, and 
cause symptoms that may be diagnosed as attention-deficit 
hyperacti vity disorder (ADHD). In one well-known tudy, it was 
found that 33% of chi ldren with ADHD exhibited symptoms of SOB 
while only about I 0% of children without AD HD in the study 
exhibited such symptoms, with the authors postulat ing a causa l 
relationship .11 This hypothe is has been strengthened by the finding 
that symptoms of inattention and hyperactivity predictably improve 
after surgica l treatment for OSAS.12 
DIAGNOSIS 
RJSK FACTORS 
Obesity is a common ri sk factor in both adu lts and children, as 
increased fatty tissue in the neck resu lts in increased upper airway 
resi tance. 13 However in childrenOSAS is sti ll most common ly 
related to adenotonsillar hypertrophy.3.7 Obstructive leep apnea is 
also assoc iated with other medica l disorders such as Down 
syndrome, anatomic crani ofac ial abnorn1a li ties such as micrognathi a, 
neuromuscular disease including cerebral palsy, and conditi ons such 
as sickle cell disease and laryngomalacia. 1 Children with any of these 
conditi ons should be seen as high-ri sk and carefu ll y screened. 
HISTORY 
A thorough sleep hi story should be taken from the parents , aski ng 
spec ifica lly about I) snoring, 2) apneic episodes,3) laboured mouth 
breathing, and 4) restlesness.3 Habitual (nightly) snoring is the most 
sen iti ve indicator, as OSAS is rarely seen in its absence. I However, 
snoring occurs in up to 12% of chi ldren and therefore ha poor 
spec ificity. I Differentiati ng between primary noring and OSAS can 
be difficult based on hi story alone. Note that the loudness of snoring 
does not necessaril y corre late to the degree of obstruction ! 1 
Dayt ime symptoms may include excessive daytime sleepi ness, 
or more commonly, hyperactivity with attention and concentrat ion 
prob lem , possibly resulting in behavioura l difficulties and learning 
prob lems. The Canadian Paedi atric Society and Coll ege of Fami ly 
Table 1. Differences in the C linical Presentation ofOSAS between Children and Adults 
C hildren Adults 
Most Common Ri sk Factor rronsillar hypertrophy Obe ity 
Obesity is secondary) 
Daytime Symptoms Hyperacti vity!Jnattention !Daytime sleepiness 
Epidemio logical Distribution 1:1 Males to Females ~ : 1 Ma les to Females 
Polysomnograph Findings !Awakening during REM sleep !Awakening during slow-wave sleep 
Fewer arousa ls More arousals 
Most Common Treatment Surgery (adenotonsi lectomy) CPAP 
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Physicians of Canada endorse the Greig Health Record which 
recommends asking about s leep habits, daytime somnolence as well 
as concentration and irritabili ty at a ll periodic hea lth visi ts for 
children ages 6-17. 14 
The ' BEA RS' screening questions, a user-fri endl y too l that 
encourages obta ining sleep informati on from pediatric patients, has 
been shown to increase the likelihood of identifying s leep problems 
in a primary care sett ing, 15 although it has not been va lidated to 
spec ifi cally identi fy OSAS. 
PHYSICAL EXAM 
Adenotonsillar hypertrophy may be u pected on phy ica l exam by 
the observation of mouth breathing, hyponasa l speech, or direct 
visualizati on on examination of the oropharyngea l cav ity, I a lthough 
visual inspecti on may give a fa lse impress ion of tonsill ar s ize and is 
therefore not a re liable method of diagnosis.1 Referral to an 
otolaryngologist wi ll a ll ow closer visualizat ion of the tonsil s, 
adenoids, tongue base, and soft palate through fl exible laryngoscopy, 
and may detect subtl e structural abnormalities in the airway. 
Recognit ion of risk factors for OSAS such as craniofacial 
abnormalitiesor obesity on physical exam may also increase the 
clinician's suspicion of the diagnosis. 
FURTHER TESTING 
Audi otapes or videotapes taken by the parent of the sleep ing child 
may sometime be used by healthcare team to li ten and watch for 
observable apneic episodes. tudies examining the reliability of this 
method of testing have found mixed results w ith genera ll y poor 
predictive values 3 While this is a non-invas ive and available means 
of creening and may be of orne use to c lini cians, if the results are 
negative and you are still suspi cious of OSAS in a patient, they 
should be referred for a sleep tudy. 
The go ld standard for di agnosis of OSAS is a sleep study, or 
polysomnography. It will re liabl y differentiate between primary 
snoring and 0 AS, and can determine the severity of the syndrome. 
Results mu t be interpreted based on age-adjusted criteri a, as OSAS 
affects sleep patterns in children di ffe rentl y than in adults. 1 Children 
wi th OSAS ex perience greater obstructi on during REM sleep, 16and 
have fewer arousals associated with apneic epi sodes.7 Children also 
experience greater desaturation during apneic epi odes.3 Theduration 
of obstructi on req uired for a definition of apneaand the threshold 
number of apneic episode for a diagno i of a di order must be 
adjusted due to the increased respiratory rate seen at base line in 
children, and it is common to see hypoxia due to prolonged parti a l 
obstruction rather than the cyc lical complete obstruction seen in 
adults. I Thi s is known as obstructive hypoventil ation. 
Worldw ide, the demand for polysomnography i high but 
provi sion is limited and is costly. Therefore it is often diffi cult to 
obtain thi s test in a timely fashion 3 In the absence of an eas il y 
accessible s leep lab, ni ght oximetry testing may be con idered, 
measuring epi sodes of desaturation throughout the night with an 0 2 
saturation probe on the child 's finger. Thi s te t genera lly ha a good 
pos iti ve predicti ve value, but if it is negati ve the patient should sti ll 
undergo poly omnography to rul e out OSAS. 17 
MANAGEMENT 
Adenotonsillectomy is usually the most appropriate therapy for 
children with OSAS. In children with documented adenotonsillar 
hypertrophy, 75 to I 00% wi ll have symptom resoluti on as well as 
normal polysomnograph results afte r surgery.1 Patients with obes ity 
or uncorrected crani ofacia l abnormalities may see poorer results on 
post-operati ve polysomnography.1 
"BEARS" Screening Questions: 
B=Bedtime Issues 
E=Excessive Daytime Sleepiness 
A= Night Awakenings 
R=Regularity and Duration of Sleep 
S=Snoring 
Studies have repeatedl y shown dramatic improvements in 
quality of life sco res, behavioura l symptom s, depression , 
hyperacti vity and somatization for children with OSAS after 
adentons ill ectomy. 18 Interesting ly, children w ith milder form s of 
sleep di sordered breathing also show imilar improvements after the 
surgery. 
As with a ll therapies, the ri sk of the procedure must be 
considered. The mo t serious ri sks of adenotonsillectomy include 
respiratory complications, and it is thought that patients with more 
evere OSAS on polysomnography pre-op are more likely to 
ex perience respiratory compromise post-op. 12·18-20 Therefore these 
patient hou ld be ho pitalized overnight and monitored carefully 
post -operatively. 
For patients with incomplete resolution of symptoms after 
surgery, or for those patients w ho are not surg ical candidates, 
continuou posi tive airway pressure (CPAP) therapy has been shown 
to be effecti ve. 1 However, it i often not tolerated in the younger 
population and must be frequent ly adju ted to fit the growing child, 
resulting in poor compliance. 
lt is a lso important to assess for and treat behavioural sleep 
di sturbance in children diagnosed wi th OSAS, e pecially those that 
continue to have daytime symptoms. Behavioural sleep di sturbances 
including bedtime resi tance, problematic leep a ociation , and 
prolonged nocturnal awakeni ngs, have a high co-morbidity with 
OSAS in children, and independently put the child at an increased 
risk for neurocognitive and behavioural issues.21 Therefore it is 
important to implement behavioural interventions while concurrently 
invest igating and treati ng for OSA 
SUMMARY 
Primary care phy icians have an important role to play in the 
identificat ion and diagnosis of OSAS in children. However sleep 
di sorder are underdiagnosed in primary care practices, primarily 
because physicians do not ask parents about the symptoms of 
di sordered leep. In general, it i difficu lt to accurately diagnose 
OSAS on hi story and physical examination alone. However, primary 
ca re phy icia ns should be performing reg ular creening for 
symptoms of OSAS as recommended by American Academy of 
Pedi atri cs. noring is the most sensitive indicator. If clinical 
suspic ion is hi gh based on risk factors and/or hi story and phy ical 
examinati on, the chi ld hould be referred to an otolaryngolog ist or 
direct!~ to polysomnography for further testing. Complex patient , 
mcludmg mfants and those with congenital abnormalities, should be 
refened to an otolaryngologi t. It is important to identify and treat 
pediatnc O~AS early in order to prevent serious morbidity, including 
neurobehav10ural sequelae such as symptoms of inattentiveness and 
hyperactivity. 
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T he larynx serves the dual purpose of airway protection and phonation. It is covered by the epig lottis during swallowing, and i patent during re pirat ion and phonation, during which 
a ir passes past the modified sides of the larynx, the voca l folds or 
cords. The upper border of the conus e lasticus is thi ckened, which 
forms the true vocal fold s. Histologically, the outermost layer of the 
voca l fold is campo ed of tratified squamou epithe lium . Deep to 
this li es the lamina propri a, a fl exible fibrou s layer contai ning e lastin, 
collagen, and fibroblasts. The lamina propria is divided into three 
c linically important layers - superficial , intermediate and deep, 
which become gradually more stiff a the co ll agen to e lastin ratio 
increases. Deep to this membranous cover lies the body of the 
thyroarytenoid muscle. 
Phonation requires the presence of not on ly the vibratory voca l 
folds, but other upper airway structures - the pharynx, ora l and nasal 
cavities - for resonance and articu lation . Phonation is produced 
during the g lotti s cycle. The first step is the accumulation of air 
pressure beneath the approximated voca l fo lds. At a particular 
pressure, call ed the phonation threshold pre sure, the voca l fold s 
begin to part in a wave- li ke fashion from inferior to superior. The 
voca l folds are s imultaneous ly moved laterally by the a ir column, 
and quickly return to the midline due to the ir intrinsic e lastic 
properties. Thi cycle repeats approximate ly I 00 times per second in 
men and 220 times/second in women 1. The amplitude, frequency, 
wave morphology and periodicity (volume, pitch and voca l quality, 
respecti vely) are va ri ed by changes in a ir pressure and/or ti ssue 
quality. Amplitude is increased or decreased by providing a greater or 
lesser ex haled force , paired with an in crease or decrease in tens ion of 
voca l fo lds (affected princ ipa ll y by the thyroa rytenoid mu c le) . Pitch 
is increased by contraction of the cricothyroid musc le, which 
lengthens and thin the voca l fold , and decrea ed by contract ion f 
the thyroarytenoid muscle, whi ch shorten the fold and increases 
the ir mass . 
Di sorders of and di sruption s to the voca l folds may have 
devastat in g co nsequ ence in eve ryday co mmuni ca ti o n, a nd 
especially for those who re ly on thei r vo ices profe s iona lly. T hi 
arti c le wi ll address some of the most common voca l di sorders of 
profess iona l s in gers, th e ir ca use, identi fi cation , management, 
prevention , and the ro le of a multidi sc iplinary team in mainta ining 
voca l hea lth . 
VOCAL HYGIENE AN D T H ERAPY 
First- li ne treatment for many organi c voca l disorders, such as 
nodu les, po lyps and cysts is voca l therapy. Vocal therapy serves to 
impro ve voca li za ti on techn ique , a nd to minimi ze harmful 
behaviours, whil e maximi zing hea lthful one . Holmberg et al. used 
voice the rapy in the treatment o f vocal fo ld nodul es, and showed 
perceptual improvement in voca l qua li ty, and reduction in nodule 
size2 Their protocol for vocal therapy cons ists of 5 d ifferent 
approaches to vocal health, and it was concluded that the therapy as a 
whole is required to significantly improve vocal quali ty2. The first is 
voca l hygiene, which enta ils patient education on normal phonation, 
types of abu ive behaviours (voice overuse) and abusive substances 
(smoke and caffeine), and etiology and consequence of vocal 
nodules. The second i re piration - a focus on reducing the effort of 
speech breathing and exercises to tra in the proper management of air 
supply. Third are direct faci litation mea ures which aim to reduce 
loudness, coup led with "yawn-sigh" exercises, w hich relaxes vocal 
musculature and so ften vocal onset. The fourth is relaxation 
techniques and stress management. Last, the patients were instructed 
to carry over all of the above techniques to real ituations2. One 
randomized control trial demonstrated the efficacy of voca l therapy 
in pati ents who acquired voca l impairment after treatment (either 
laser o r radi o therapy) for early g lo ttic cancer. Significant 
impro ement were no ted bo th subjective ly by patient questionnaire 
and through objective vo ice parameters3. 
A econd e lement in voca l technique is the voca l warm-up. 
Warm-up exerc ises inc lude !retches of the face and torso, deep 
breathing tri gger , sustaini ng vowel on various pitches wi th varyi ng 
intens ity, humming and lip-buzzing, g lide , and the production of 
con onants. The a im of the wann-up is to maximi ze phonation, 
resonance and respira tion. Elli ot e t al. , hawed that voca l warm-up 
reduces vi cos ity of the voca l fo lds, but that this result a lone does not 
uniforml y increase ea e of phonati on (phonation thre hold pres ure) 
among subjects4• It is in tead hypothe ized that the voca l warm-up 
affect othe r properties of the voca l fold s, uch as amplitude, 
vibrati on peri odic ity, and nervous cont ro l of laryngea l muscles4.5. 
Bay lock conducted pre liminary research that studied the effect of 
voca l-wam1 up in four ubj ects with vo ice di sorders6. He reported a 
s ignifi cant improvement in voice production accordi ng to acou tic 
mea ures and se lf- rating, but noted that more studies were needed to 
corroborate these re ults6 A recurring prob lem in the li terature seems 
to be the inte r-subject variab ili ty in vocal physiology, and the 
d ifficu lty o[ findin g an adequate measure to asses the different 
effects of the warm-up4•5•6. Therefore, the efficacy of wam1 up in 
vo ice di sorders is still inconclusive. 
A third cons iderati on in the management of any voca l di sorder is 
the prompt treatment of secondary dysphonia . Examples are acid 
reflux , acute laryngiti s, and a ll ergic laryng itis . One of the mo t 
important c~uses that should be ruled out is laryngopharyngea l re flu x 
(LPR). Un hke the stomach the larynx does not have the intrinsic 
ability to protect from gastric acid re lated muco a l damage7.11 . In 
add1t1 o~ to the mherent u ceptibility of the la rynx to aci d damage, 
carb~mc a~hydrase type 3 ( important in regulating pH by producing 
a lkalme bicarbonate) IS normall y present in true voca l fo ld 
however, dimini shed or absent in voca l fo lds affected by LPR7. The ' 
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symptoms of LPR include throat clearing, hoarseness, excessive 
mucus, cough, globus sensation as well as laryngoscopic findings 
which include posterior laryngeal edema, true voca l fold edema, and 
p eudosulcus9•11(Figure 2). The genera l approach to the treatment of 
LPR is simi lar to the treatment of gastroesophagea l reflux9. Dietary 
modifications consi t of limi ting foods and beverages containing 
caffeine, alcohol and peppermint, which may weaken lower 
esophagea l sphincter tone 11 . The ev idence surrounding the use of 
PPis for the management of LPR remains somewhat inconclusive9- 11 . 
However, for patients with LPR who have symptoms that impact 
their profess ional or socia l responsibilities (like singers, actor , 
lecturers), it is recommended that treatment with PP!s be started at 
high do es 11 , as well a administration of H2 blocker and antacids 
when reflux is anti cipated after meals9 
In all cases of voice di sorders, a multidisciplinary team 
consisting of oto lary ngo logis ts, family physicians, speec h 
pathologists and voca l teachers are required . While speaking voice is 
sometimes unaffected by voca l fold lesions, the reduced vocal range, 
increased effort and impaired endurance experienced by professional 
singers, have far greater implications to their ca reer12. The pos ibility 
of secondary causes of dysphonia such as LPR, hi ghlight the 
significance of a thorough hi story and physical , which can revea l risk 
factors and possible etiologies that lie outside the larynx. The role of 
the family physician is parti cularly important in isolating and 
directing appropriate treatment or referratl 4 The role of the speech 
language pathologist lies in the education of regul ar speech, assisti ng 
in phonati on, articu lation, respiration and resonance12 Voca l teachers 
contribute specia lized experti se in vocal hygiene, wam1 ups and 
education of proper singing techniques, as well a profess ional 
guidance. Not surpri singly, it is wide ly appreciated that combined 
interdisciplinary treatment modalities support better outcomes for 
patients 12-14. 
PROBLEMS FOR SINGERS: VOCAL FOLD LESIONS 
Benign vocal fold le ion are common in profe sional vo ice u er . 
The most likely culprit of these lesions include voca l overuse, misuse 
(excess ive musc le tension) and ab use (voice ove ru se or 
whispering) 15. During any of these acts, there is excess ive 
mechanical stress applied to the voca l folds. The mechanica l stres of 
excess ive vi brations of the voca l fold affect the voca l fold mucosa 
itself, rather than the underl yi ng musculature16·17, resulting in fatigue 
damage18. Vocal ti sue traumatized by repeated co lli sion forces, 
vocal fold accelerations and decelerations, and heat di ssipation, 
which result in tissue breakdown and remodelling16·17·19 The 
remodelling phase induces mass lesions, including voca l fold 
nodules, polyps and cyst . While the histo logy and pathology of 
benign vocal lesions is not fully understood, some studies try to 
correlate the different types in order to detem1ine the best pos ib le 
management15. 
Vocal polyps are benign, hyperplasti c lesions of the laryngea l 
mucosa. They are normall y si tuated unilaterall y20 and anteri orl y on 
the vocal fold21. It is hypothesized that voca l polyp are due to areas 
of vibration-induced hyperaemia and vasodil ation resulting in 
edema21 . The edema then leads to degenerati on or fibrosis21. Vocal 
polyps are also associated with smoking and acid reflu x22 . First-l ine 
treatment is generally regarded to be voca l behav ioural therapy' S, but 
debate remains over whether patients should primarily attempt voca l 
therapy measures (as in the case of voca l fold nodule ), or proceed 
immediately to s urgica l inte r ve nti o n . A we ll-d efin ed 
microphonosurgery ex ists, developed by Hochman and Zeitels, 
which preserves more of the voca l fold microstructure than typical 
cold instrument or laser removal22 . Stajner-Katusic et al. , in vestigated 
the vocal quality of fi ve males, before, one month after and six years 
after surgical vocal polyp removal. Their data showed significant 
improvement of vocal quality across several voca l measures, 
including elf-estimation by the participants23 . Conversely, Cohen 
and Garrett showed that voca l therapy was effect ive in improving 
voca l quality, by reducing the size of voca l polyp (but not 
eliminating voca l polyps) in 50% of their participants, while the 
other half required surgery24 The response to treatment was 
attributed to the polyp type. Translucent (immature, edematous) 
polyps, seen by videostroboscopy, were significantl y more likely to 
benefit from voca l therapy, when compared to fibrotic , hya line, or 
hemorrhagic (matu re) polyps24 In add ition, incomplete glotta l 
closure after voca l therapy was di scussed as a potential indication for 
surgica l referral. Without glotta l closure, ai r would sti ll escape during 
si ngi ng and phonation, resulting in persistently inefficient vocal use, 
sugge ting the need for aggressive treatment24 . ln this study, long-
tem1 follow-up wa not performed, and there was no accounting for 
differences in methodology between voca l therapists. It was 
concluded that although not for everyone, there is a speci fi e patient 
populati on that would max imall y benefit from voca l therapy alone, 
while others should proceed directly to surgery24 
No dul es , o r " si nger 's nodes" occ ur bilaterally a nd 
symmetrica lly on the voca l fo ld and are attributed primaril y to voca l 
abuse or misuse 11 ·25(Figure 3). Vocal fold nodules, similarly to 
polyps, are benign areas of edema and fibrosis25. It is worth noting 
that the difference between nodul es and polyps is not always evident, 
and there is a lack of clear hi stologica l distinction20 Vocal fold 
nodules present with hoarseness and breathiness due to a fa ilure of 
the vocal folds to approx imate, pitch breaks and fat igabi li ty25 . As 
detailed above, the fir t line treatment for voca l nodules is 
behaviourall y-ba ed vocal therapy3 An intervention review in 2009 
found that there were no high quality randomized controll ed trial , 
which compared surgica l and non-surgica l interventions for vocal 
nodules26 The article reiterates the lack of definite hi tologic 
di stinction between nodules and polyps, as well as the lack of gold-
standard assessment measures of voca l quality a barriers to 
performing adequate trials26 Other voca l fold pathology that is 
important to rul e out by an otolaryngologist, include laryngeal 
papi llomatos is, granulomas, dysplasia and carci noma, all of which 
have been documented in singers as causes for voice impairment. 
CONCLUSIONS 
Like many other occupational hea lth issues, dysphonia is associated 
with decreased quality of life, and may lead to loss of work in 
popul a ti o ns whose profess ions re ly o n vocal ab ility27 
Otolaryngologists provide a major role in both surgical and non 
surgical correcti ons of nodules that are not amenable to con ervative, 
behavioural or voca l therapy treatments. Surgery was once beli eved 
to be profess ional sui cide for singers a decade ago 13, but thi s rapidly 
changing perspective reflects the advances in microsurgery that have 
created positive outcomes for appropriately selected patients22,24 
Voice medicine reiterates the importance of multidisciplinary care 
and combined experti se that cater to the overall goals of a particular 
patient population . A always, health care profe sionals should be 
aware of these modalities that lie outside of tradi ti onal medicine. 
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Transoral Robotic Surgery (TORS) 
Jason Xu {Meds 2013), Michal Brichacek (Meds 2013) 
Faculty Reviewer : Dr. Kevin Fung, Dr. Anthony Nichols 
M inimally invas ive surgery has revo lutioni zed surgica l practice in the past two decades and is quickly becoming the tandard of care aero s multiple di sciplines. In head and 
neck surgery, organ-preservation protoco ls and transora l laser 
microsurgery have laid the foundat ion for the recent development of 
transoral robotic surgery (TORS), which uses the da Vinci surgica l 
robot to orally approach the throat rather than traditi onal cerv ica l 
incisions into closed neck spaces. ! The technique was developed at 
the Univer ity of Pennsylvania, initiall y by demonstrating wide 
access to the laryngopharynx using mouth gag retractor and 
perfom1 ing procedures on a canine mode l. lin 2006, they descri bed 
its appl ication in human patients fo r resection of oropharyngea l 
squamous ce ll carcinoma (OPSCC).3The FDA approved the use of 
TORS in December of 2009 for resecti on of selected head and neck 
tumours.2 
In December of 20 I 0, Dr. Kevin Fung and Dr. Anthony N ichols 
from the Department of Oto laryngo logy - Head and Neck Surgery at 
the University of Western Ontario (UWO) performed the first TORS 
procedure in Canada: a TORS upraglottic laryngectomy(Figure I ). 
Other options fo r the pati ent were e itheropen suprag lotti c 
laryngectomy with bilatera l neck dissecti ons or full course 
radiotherapy for 7 weeks (70 Gy) . With TORS, the patient was able to 
avoid temporary tracheotomy and nasogastric tube (NG) feeding, and 
with negative margins and nodes the patient completely avoidedpost-
operati ve radiotherapy as we ii.Thi case hi ghlights some of the 
advantages of TORS fo r the treatment of head and neck cancer, 
which wi ll be discussed fu rther below along with detail s of the 
procedure and future directions. 
SURGICAL PROCEDURE 
The Da Vi nci surgical platfo rm consists of a conso le, a surgical 
cart, and a manipulator unit. The TORS procedure in vo lves the 
transoral inserti on of two wri sted instruments anns and a central 3D 
endoscope.4 The console offers the surgeon a three-dimensional 
magnifi ed view and allows control of the twoendowristed roboti c 
anns, whi ch helps to enhance manual dexterity.5 The system a ll ows 
for the surgeon's hand movements to be motion-sca led and thereby 
eliminates physiological hand tremor. 6 
The first clinica l use of the Da Vinci robot fo r head and neck 
surgery involved the remova l of a benign oropharyngeal lesion and a 
thyroidectomy. 7 ,&Applications have expanded to procedures such as 
parathyroidectomy and skull ba ed surgery.9, I OHowever, the main 
application of TORS is in the treatment of malignancies caused by 
squamous cell carcinoma (SCC) which can invo lve the oral cav ity, 
oropharynx, hypopharynx, and larynx .6Such cases include TORS 
tonsillectomy, TORS tongue base resection, and TORS supraglotti c 
laryngectomy. 
The primary adva ntages of roboti c surgery include the 
minimizati on of surgica l trauma, superior visuali zati on, improved 
precision, and the abili ty to recreate an open surgica l experi ence.6 
Additional advantages include better safety and morbidi ty outcomes 
for the patient, which are di scussed below.Conver ely, there are 
certain di sadvantages ofTORS such as a confined operati ve fi e ld and 
fin ancial limitations such as the high initi al cost of the roboti c system 
(over a milli on dollars) and the high cost o f instruments (about one 
thousand doll ars per ca e) .l However, in centers where a robotic 
console a lready ex ists for general or urologic surgery, adding head 
and neck cases wi ll augment value of the machine and increase 
producti vity. I 
Figure l. Dr. Anthony Nichols (left) and Dr. Kevin Fung (right) from 
the Department of Otolaryngo logy - Head and Neck Surgery at the 
Uni versity of Western Ontario,standing next to the control console of 
the Da Vinci surgica l robot. 
OUTCOMES 
Due to its relati ve in fa ncy, there are currently no contro ll ed studies 
comparing TORS procedures to their open surgical counterpart or 
primary chemoradiation for the treatment of oropharyngea l cancer. 
However, di ffe rent case series of patients who underwent resection of 
oropharyngeal squamous cell cancer (OPSCC) by TORS show 
promising re ults and highlight several advantages . 
SAFETY 
No major complicati ons and acute sequelae of TORS have been 
re ported . Mino r co mpli ca ti ons inc lude tran so ra l bleeding, 
exace rb a ti o n of s leep apnea fro m posto pera ti ve we lling , 
development of moderate tri smus, and temporary hypem asali ty of 
voice. lin general, patients who undergo TORS have lower estimated 
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blood loss (<200 mL) when compared to open surgery, and none 
have required blood transfusions. ! TORS patients a lso have a shorter 
ho pita! length of stay, as most are di scharged six days after OP CC 
re sec tion .3 ,4ln co ntras t , patient after ope n s uprag lottic 
laryngectomy wou ld typically stay I 0-14 day in ho pita! post-
operatively. 
ONCOLOGICAL 
OP CC re ection with negati ve margins in a ll patients was reported 
by different ca e series ranging from 12 to 45 patients.4, II , 14- 16 For 
example, in the case series from the Mayo c linic, a ll 45 patients with 
ei ther ba e of tongue or tonsillar fo a tumors had negative margi ns 
after TORS resection, and 12 were able to avoid adjuvant radi ation . 
II A recent publication from the Univer ity of Pennsylvania reports 
that, out of 50 cases, 2 patients developed distant metasta es and one 
patient developed both loca l and di stant recurrence of di ease 
following TORS resection of OPS (mean follow-up : 2 years). 
19More long-term onco logical outcomes are unavailable at thi s time. 
FUNCTIONAL 
Pre erving airway and swa llowing functi on is an important 
determinant of quality of life followin g oropharyngeal surgery, and 
large ly depends on whether the patient receive po !-operati ve 
radiation or chemotherapy. To date, none of the four patient treated 
with TORS at UWO have required adjuvant radiation therapy a they 
al l had negati ve margin and nodes po t-surgery (negative nodes 
weredetermined by pathological staging of a taged neck di section 
two weeks post-TORS). In the event that patients do have positi ve 
node , the adj uvant rad iation do age needed (60Gy) will be smaller 
than primary radiation treatment (70-72Gy), minimizing s ide effects. 
At other centers, reported rates of temporary tracheotomy in 
patients who undergo TOR range from 3% to 31 %, with an average 
time to decannulation of even days.4, II , 15The use of Gtube for 
enteral feeding shows greater variance due to surgeon and center 
preference. In a case series of 45 patients at the Mayo clini c, 
Gtubes were used in 48% of patients, with a mean durat ion of 12.5 
day .4 In another case erie of 18 patients at the Mount S inai choo l 
of Medicine, no feedingtubes were used and patients were fed a 
pureed diet one day after urgery. I4These data suggest an advantage 
over primary chemoradiat ion , w here 17-30% pati e nts a re 
gastrostomy-tube dependent after one year due to dysphagia 18, and 
open surgery, where all patients are typ ica lly kept on NG tube for 
several weeks due to a pi ration ri k. 
FUTURE DIRECTION 
With the increasing popularity of robotic surgery, training guideline 
and opportunities mu t be developed for current practitioner looking 
for certifi cation . Similarly, a more re idency programs acquire robot 
access, standardization of res idency and fe ll ow hip curri culum w ill 
a lso be important. Currently, a ll Head and Neck Surgery fellows 
graduating from the Un iver ity of Penn ylvania are trained in TOR . 
I The university a lso runs a TORS tra ining program for surgeon 
from around the world . 
As surgeons become more comfortable with TORS, new and 
innovati ve procedures are being deve loped as well. One exampl e is 
transax i ll ary thyroidectomy, where the thyroid gland i removed 
without having to create an unaesthetic cervica l scar. The procedure 
was developed in Korea and has been performed in over 300 patients 
a of2009.17 
CONCLUSIONS 
TORS is a safe and minima ll y invasive surgical techniquewith 
many applications in head and neck urgery. Benefits of TORS over 
tradi tional open surgery include hand tremor reduction , better 
visualiza tion , and minimization of surgica l trauma. Promis ing data 
from case series uggest possible benefit of TORS over primary 
chemoradiation at preservation of wallowing function after resection 
of oropharyngea l tumours. This offersa very ad_vantageous quality of 
life consideration, especially for the increasmg mctdence ofOPSC~m 
young HPV-posi ti ve patients. l9 However, long-ter_m oncologtcal 
outcomes of oropharyngeal cancer afterTORS resection are not yet 
ava ilable, and further tudies are warranted . 
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The role of FOG-PET and PET/CT in the 
diagnosis and staging of head and neck 
cancer 
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Faculty Reviewer : Dr. John Yoo, Department of Otolaryngology - Head and Neck Su rgery 
A n estimated 644,000 cases of head and neck cancer are di agnosed worldwide each yea r, w ith head and neck squamous cell carcinoma (HNSCC) accounting fo r over 90% 
of these. Common presenting s ites inc lude the ora l cav ity, 
oropharynx, nasopharynx, hypopharynx , and larynx. I While chronic 
tobacco use and alcohol consumption are well -establi shed ri sk 
factors,2 human papillomavirus (HPV) infection of the upper 
aerodigestive tract has been cau a lly li nked to tumorigenesis.3 In 
particular, the increasing rates of oropharyngea l cancers, especially 
young non-smokers, has been directly attributed to HPV infect ion. 
The diagnostic workup of HNSCC typically incl udes history 
and physical examination, endoscopic-guided biopsy and high-
reso lution contras t-enh anced computed tomograph y (CT) o r 
magnetic resonance imaging (MRI). Whil e CT and MRI have 
traditionally been the cornerstones of the imaging workup, 2-fluoro-
[ 18F]-deoxy-2-D-glucose positron emission tomography (FDG- PET) 
plays an increasing role in the diagnosis, raging and fo llow-up of 
HNSCC patients.! ,4,5 
FDG-PET AND PET/CT IMAGING 
FOG, a glucose ana log labe ll ed with the radi onuclide 18F, 
preferentially accumu lates in cell s that have an increased g lyco lytic 
rate - a characteri stic fea ture of cancer cell s.6 FDG-PET is thus a 
fu nctional imaging modality that detects cellular metabol ic changes, 
unlike CT and MRI , which re ly on structura l abnormali tie . The 
positrons emitted by the radi onuclide annihilate nearby electrons and 
create photons that are captured by an array of detectors and 
reconstructed into a 3D image. A lthough PET a lone is limited by its 
lack of anatomic localizati on, the advent of the hybrid PET/CT 
scanner has overcome thi s by fu sing PET and CT images acqu ired in 
a single session, permitting deta iled visualizati on of both structural 
and functional aspects of di sease. I ,4-6 
STAGING OF HEAD AND NECK CANCER 
TNMSTAGING 
HNSCC is staged according to the size and extent of the pri mary 
tumour (T), regional lymph node involvement (N) and the presence 
of distant metastases (M).4 Accurate staging at the time of di agnosis 
is the most important factor for planning manage ment and 
determining prognosis.4,7 Since the preservation or restorat ion of 
function is a top priori ty in the management of patients with HNSCC, 
fu ncti on-sparing strategies such as minimally invasive surgery or 
(chemo)radiotherapy are often considered as fi rst- line treatments .& 
Thorough clinica l assessment, including imaging, is vita l to optimal 
staging of HNSCC. Furthermore, re-evaluation of patients fo llowing 
treatment may be especiall y challenging in HNSCC, due to difficul ty 
in obtaining pathology. The fo ll owing subsecti ons review the c li nica l 
indications for FOG-PET and PET/CT in staging HNSCC. 
PRJ MA RY TUMOUR 
Whil e PET and PET/CT have been shown to be at least as effecti ve 
as CT or MRI at detecting primary tu mours, these modali ties are not 
used in tandard practice to T- tage newly di agnosed HNSCC 
because their anatomic reso lution is not as hi gh as that of MRl or 
contrast-enhanced multi slice CT.9- I 3 An early tumour may have 
poor FOG uptake and its detection on the scan may be obscured by 
cross contamination of physiologic acti vity from surrounding ti ssues 
- the so-ca ll ed 'spillover effect' . l4 CT and MRI are usefu l fo r initia l 
T-staging, since the ir high spat ial resolution and soft-tissue contrast 
can demonstrate subtle abnormaliti es and accurate ly delineate 
tumour volume. 
CARCINO MA OF UNKNOWN PRIMARY 
In 2-9% of patients with newly di agnosed HNSCC, cervica l node 
metastases are clinically ev ident at biopsy but the primary tumour 
cannot be identified by conventi ona l workup, which includes 
physica l examination, CT, MRI and endoscopic-guided biopsy. l 5 
PET/CT has proven to be sign ifi cantly more sensitive than CT (94 .0 
versus 7 1.6%, respectively, P < 0.00 I) at detecting carcinomas of 
unknown primary. l 6 Rusthoven et al. reviewed 16 studi es published 
between I 994 and 2003 and found that among 302 patients with a 
negati ve conventional workup, FOG-PET detected the primary 
tumour in 74 patients (24.5%).17 In a more recent review, Al-
lbraheem et al. performed a meta-analys is of 8 stud ies publi shed 
between 2000 and 2009.5 FOG-P ET or PET/CT were able to detect 
the unknown primary in 5 I of 180 patients wi th an otherwise 
inconclu ive workup . Delineation of a pri mary tumour i e sential fo r 
delivering targeted therapy, minimizing therapeutic morbidi ty caused 
by wide- fi eld irradiation and improving prognosis. IS A recent report 
noted that findin gs made by FOG- PET changed therapeuti c 
management in 25% of pati ents. l9 In light of th is evidence, PET/CT 
may have an important ro le in the di agnosti c assessment of 
carcinoma of unknown primary.5 
CERVICAL NO DE METASTASES 
Cervica l node status is the most important prognosti c factor in 
HNSCC.7 Cure rate declines by nearly 50% when cervical 
metastase are present.20 Metastatic lymph nodes are found in 
approximately half of patients at the time of di agnos is.2 1 PET/CT 
has been shown to have better sensiti vity and specificity for 
pathologic cerv ica l nodes than MRI and CT, likely because the latter 
rely on nodal size and contrast-enhancement criteri a which are not 
specific and can miss metastase in normall y sized nodes .22 ,23 
Nevertheless, CT is generally used for loca l staging of clinically 
mani fes t cerv ica l nodes at initial di agnosis, due to its c linical 
ava ilabili ty and accurate T-staging of the primary tumour. 
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CLINICALLY NEGATIVE (NO) NECKS 
l f clinica l examination fa ils to identi fy metastati c cervica l lymph 
nodes in patients with primary HNSCC, these patients are sa id to 
have a clinica lly negati ve (NO) neck. Since the probabili ty that these 
patients actuall y have a pathologica l neck varies between I 0-45%, 
elective neck di ssection is recommended in cases where the ri sk of 
occult cervical mets is greater than 20%.4 While PET/CT is the most 
accurate imaging modality for detecting occult metastases, the role o f 
PET/CT in the asse sment of NO necks is st ill controversia l. ? 
Microscopic di sease or nodal metastases located adjacent to the 
primary tumour may evade radiographic detection and contribute to 
fa lse-negatives. Two studi es reported sensitivity and specifi city 
ranging from 67-79% and 82-95%, respecti vely, leading the authors 
to conclude that PET/CT is not yet accurate enough to inform the 
need for surgical di ssecti on in cases of occult nodal disease.24,25 
SECOND PRIMARY (SYNCHRONOUS) MALIGNANCY AND 
DISTANT METASTASES 
Pati ents with advanced HNSCC are at higher ri sk for deve loping 
distant metastases and for presenting with a second primary 
(synchronous) tumour;26 the latter being defin ed a a hi sto logica lly 
dist inct malignancy, separated from the primary tumour by at least 
2cm of normal muco a.27 The cost of mi ssing distant metastases or 
synchronous tumours at the time of initial diagnosis is high. Curati ve 
therapies a re ofte n assoc iated w ith s ig nifi ca nt mo rbidity, 
necessitati ng the careful se lection of patients with nonmetastatic 
di sease who may benefit from the treatment and not eventually 
succu mb to previously undetected di stant di sease .28 Aggressive 
subtypes, such as nasopharyngea l carcinoma, have a tendency to 
metastas ize to the lungs, li ver and bone; hence, the conventional 
imaging workup fo r di stant metastases is comprised of chest 
radi ography, abdominal ultrasound, and skeletal scintigraphy (bone 
scan). Several reports have assessed the efficacy of PET/CT in 
staging di stant metastases and synchronous tumours and found that it 
is the most sensiti ve, spec ific and accurate modali ty and may replace 
conventional techniques. l4,28,29 A multicentre prospecti ve study of 
92 patients found that PET/CT had a higher ensiti vity (63%) than 
chest CT (37%), due to its abili ty to image the whole body with a 
single scan and detect di stant hypermetaboli c foc i.30 PET/CT can 
therefore be considered as the moda lity of choice for the diagnostic 
workup of di stant metastases and synchronous tumours. 7 
RESIDUAL AND RECURRENT DISEASE 
The reliance o f CT and MRl on morpho logic criteri a often makes the 
detection of post-treatment residual tumour acti vity or recurrent 
disease diffi cult, s ince the regiona l head and neck anatomy may be 
di storted a fter therapeuti c (chemo)radiotherapy and/or urgery.4 Al-
lbraheem et a l. rev iewed the utili ty o f PET and PET/CT for 
identi fy ing disease recurrence in head and neck cancers.5 Among 7 
studies published between 2004 and 2009, PET or PET/CT 
demonstrated hi gh sensiti v ity (83 -1 00%) and relatively h1gh 
specificity (78-98%) and accuracy (~1-90%~, oft~n significantly 
outperforming CT and MRI. InflammatiOn and mfe~t10n are common 
treatment sequelae that may increase FDG uptake_ m certam . tissues; 
hence the addition of CT to PET is espec1ally Important m these 
situat{ons in order to distingui sh truly patholog ic areas from post-
irradi ated ti ssue. l2 ,22 The anatomica l landmarks provided by CT 
have been s how n to dec rease the number of equivocal 
hypermetabo lic foci and there fore reduce the amo~nt non-invasive 
imaging and invasive biopsies required for d1agnosts of recurrence. 
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LIMITATIONS 
F a/se-positives 
In addition to the post-irradiati on changes di scussed above, increased 
FDG uptake may occur in benign hyperplastic conditions such as 
thyroid or pleomorph ic adenomas . Regiona l physiologic FDG uptake 
in lympho id ti ssue, a li vary g lands, strained or excessively used 
skeleta l muscles and activated brown fa t ti ssue may a lso confound 
interpretation and be erroneously attributed to malignancy.4,6 It is 
recom mended that posi ti ve results be conflfllled by biopsy.6 
False-negatives 
Since the patial resolution of FDG-PET is limited to 4-1 Omm, it 
abili ty to precisely loca li ze sma ll tumours or microscopic tissue 
involvement is often dimini hed in the head and neck region. 
Tumours with low metabolic rate and poor avidity for FDG uptake 
may also be difficult to characterize on PET scans.6 
SUMMARY AND RECOMMENDATIONS 
In 2009 , Yoo and Walker-Dilks reviewed the data and made 
recommendations for the use of FDG-PET in head and neck cancer. 
3 1 The gu idelines, part of an initiative of the Program in Evidence-
Based Care for Cancer Care Ontario, are consistent with the findings 
reviewed here and are summarized in Table I . It is worthwhi le to 
note that studies examining PET and PET/CT were not distinguished 
in the report ; however, the hybrid system clearly confers a diagnosti c 
advantage over ei ther modali ty alone.4-7 De pite its limitations, 
increa ing use of PET/CT for the diagnosis, stag ing and follow-up of 
HNSCC pat ients ha provided physicians with a powerful tool that 
will continue to improve patient outcomes as the technology 
advances and clinica l guideline are re fined . 
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Marijuana use: sequelae and implications for 
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A s of 2003 , 40% of American aged 12 yea r and older had smoked marijuana at least once. 1 Approximately 30% of Canadian youths from Grades 7-1 2 have tried cannabi s at 
least once.2 Marijuana is the most widely-used illic it substance in 
Canada, with l 0.6% of the Canadian popu lation reporting u e in 
2009.3 Thi s is si milar to the US annual fi gure of9%.4 Global reports 
indicate that the average age o f first marijuana use is decreas ing, 
even as the average delta-9-tetrahydrocannabinol (THC) content of 
cannabi s is on the rise. This may lead to an increase in both addicti ve 
potential and adverse effects of marijuana use. 5 
A survey of the adult US population comparing fi gures from 
1992 and 2002 suggested that the prevalence of marijuana use 
remained stable over the decade, but the prevalence o f marijuana 
dependence increased significantly. Thi s increase in marijuana use 
disorders has occurred in the absence o f increased frequency or 
quantity of marij uana use, suggesting that the enhanced potency of 
THC may have lead to the rise in rates 6 Treatment admi ssions for 
cannabi s abuse have ri sen steadily over the past ten years, including a 
2-fold increase in the US and 3-fold increases in Australia and 
Europe.7 
Although publi c perception remains that cannabi is "softer" and 
less dangerous than other illi cit substances, cannabis use is becoming 
a major publi c hea lth concern ; some research even sugge ts it may 
serve as a gateway drug to "harder" substances.s Furthermore, 
mul tipl e studies have shown an increa ed ri sk in marij uana users of 
other long-tenn hea lth consequences . In thi s paper, we review current 
research and understandipg of marijuana's impact on hea lth 
outcomes. We also prov ide an overview of at-ri sk popu lati ons for use 
and abuse of marij uana, summarize marijuana' potenti al positi ve 
e ffects, and di scuss implications for hea lth promoti on and various 
levels of preventi on. 
PULMONARY EFFECTS 
Numerou s studies have shown that the combustion of tobacco and 
marijuana produces s imil ar hannful compound .s,9 The ri sks of 
marijuana may be increased by three factors. Marijuana smoke has 
three times more tar and 1.5 times more carcinogeni c substances than 
tobacco smoke.10 Marijuana smoke is typica ll y inhaled more deeply 
and held in the lungs longer: there is more time for depos ition of 
parti culate matter. Furthermore, marijuana cigarettes do not conta in 
the same filter apparatus as conventi onal tobacco cigarettes. On the 
other hand, even heavy marijuana use invo lves far le s smoke 
inhalation than the equiva lent amount o f tobacco in a pack-a-day 
smoker. One analy is of 19 previous studies defined marijuana use 
as smoking I 0 or more marijuana cigarettes per week for 5 or more 
years.1 One pack o f tobacco cigarettes contains 20-25 cigarettes, and 
the cigarettes generally contain more combustib le materi al than their 
marijuana counterparts. 
Smoke - whether from marijuana, tobacco or any other combustible -
is noxious to the airways. Thi s stimulates short-term bronchitic 
reacti ons, including coughing, sputum production and wheezing. In 
tum, these activate the mucocili ary esca lato r, whi ch carries 
parti culate matter from the bronchi cranially to be expectorated or 
swall owed. 
One systemati c rev iew found that inhaling marijuana smoke can 
cause clini cal dyspnea and pharyng iti , as we ll as exacerbating pre-
ex isting pulmonary illnesses such as asthma and cysti c fibrosis; these 
effects persi ted after adju ting fo r concurrent tobacco use. 5 Despite 
these apparently harmfu l effects, the review fo und no a sociation 
between marijuana smoke inhalation and effects on FEY I (forced !-
second expiratory vo lume) or FVC (forced vital capacity), DLco 
(diffusi ng capacity of the lung of carbon monox ide) or airway 
hyperreacti vity. The authors explained these findings by sugge ting 
that cannabinoid promote the Th-2 anti- infl ammatory immune 
response while nicotine suppres es it. One study noted that the use 
of a vapourizer when consuming marij uana was associated with 
decreased respiratory sym ptom . 11 A vapourizer is a device that 
heats the marijuana to the vaporiza ti on point of the cannabinoids 
without the use of flame, thereby obv iat ing the consequences of 
smoke inhalation. Although there are many confounders in these 
analy es, not the least of which is the fac t that many marijuana users 
cut the dried marijuana with commercially-ava ilable tobacco, it can 
be concluded that smok ing marijuana exacerbates pre-ex i ting 
respirato ry co mpl a ints by directl y irritating th e respiratory 
epithe lium . However, contrary to tobacco moke, marijuana smoke 
does not seem to cause ob tructive pulmonary di seases. 
LUNG CANCER 
The _extant_ litera ll.~ re on marijuana and lung cancer presents 
confl1ctmg mfo rmatlon. On the one hand, marijuana smoke contain 
benzopyrene, a carcinogenic hydrocarbon also found in tobacco 
smoke, which has been _implicated in mutations related to lung 
cancer. Ex penmenta l tud1es have also demonstrated THC-induced 
ma lignant cell pro life rati on and suggested that THC inhibits 
antitumour immunity, thu s promoting tumor growth. In contrast, 
other v1tro m~de l s suggest that cannabinoid may actua lly exhibit 
ant1carcmogen1 c effects. 12 In an attempt to reconc ile these di veraent 
streams o f thought, Mehra, Moore, Crothers et al. undertook a 
systematic review to detennine the associations between marijuana 
mokmg
1 
and lung cancer incidence, -~i sk factor , or premalignant 
changes. The author found that manJuana smoking bas increased 
tar de_hve~ ~o lungs compared with cigarettes, and marijuana smoke 
contams s1mdar carc inogen as tobacco smoke, o ften in increased 
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concentrations. Marijuana smoking was associated with the presence 
of more metaplastic cells, impai red alveo lar macrophage function , 
and increased oxidative stress when compared with non-smokers. Six 
studies included in the systematic review reported hi stopathologic 
and molecular findin gs from bronchi al biopsy; in a ll studies, 
marijuana smokin g was a soc ia ted with a bn o rm a l a nd/o r 
precancerous alterations when compared with e ither non-smoker or 
tobacco smokers. One study in particular reported an additi ve effect 
between marijuana and tobacco use. All the e findings suggest a 
biological plausibility for the association between marijuana use and 
lung carcinogenes is. However, a cohort study of 65,000 subj ects 
showed no increase in lung cancer incidence in marijuana smoker 
after contro lling for tobacco use. The authors suggested that there 
may be methodological concerns underpinning the lack of empiri ca l 
support fo r increased lung cancer incidence in marijuana users, 
including the need for more detailed assessment of marijuana 
exposure and longer follow-up periods. They a lso cautioned that 
physicians should still advise their patients of the potentia l adver e 
health effects of marijuana use, including premali gnant lung changes . 
I 
While methodological factor may we ll account for the lack of 
evidence for an association between lung cancer and marijuana use, 
Melamede 13 ha summarized another line of thought: although 
marijuana and tobacco smoke contain s imilar carc inogen , 
cannabi noids and nicotine present with very different cellular effects. 
Firstly, although low-doses of THC may indeed promote tumour 
growth, the response appears to be biphasic; a lternate doses of 
cannabinoid have been capable of destroying cancer cells (including 
lung, breast, prostate, skin, and g lioma) in vitro and in animal 
models. Secondly, both nicotine and cannabinoid receptors are linked 
to signaling pathways that can tum on anti-apoptosis (i.e. preventing 
cell death). Nicotine receptor are found in respiratory epithe li al 
cells, whi le cannabinoid receptors are not. As such, when nicoti ne 
receptors are st imulated in respiratory cell s, there is an anti-apoptotic 
signal; the prevention of cell death under exposure to such mutagenic 
conditions (i.e. smoking) is likely to amplify carcinogenic potenti al. 
Thirdly, while nicotine promotes neovascul arizat ion and thus tumour 
growth, cannabinoids inhibits angiogenesis and results in tumour 
regression. Finally, the introduction of particulate matter and 
carcinogens into the respiratory system results in the creation of a 
pro-inflammatory state . In this ci rcumstance, cannabinoids reduce 
the associated free radical production by dri ving a re lative ly anti -
inflammatory Th2 immune cytokine profile. Melamede suggests that 
all these critica l factors can ex plai n the lack of association between 
cannabis use and lung cancer.13 
Even in light of this controversy surrounding cannabinoids and 
their association with lung carcinogenesis, Guzman has gone so far 
as to suggest that cannabinoids could be used to deve lop novel 
anticancer therapies.14 In additi on to evidence uggesting inhibition 
of tumour growth, marijuana may a lso be beneficial to chemotherapy 
patients- it has the potentia l to miti gate nausea, vom iting, and pa in 
while also stimulating appeti te. 
NEUROPSYCHOLOGICAL EFFECTS 
Aside from its respiratory and pulmonary effects, marijuana use has 
been associated with neuropsychologica l consequences. Chroni c 
marijuana use has hi storica lly been associated with impaired 
cognition, including reduced attention, memory, higher cogniti ve 
function (e.g. executi ve function) and psychomotor defi cits. One 
study showed that after 25 days of abstinence, moderate (8-35 
marijuana cigarettes/week) and heavy (53-84 marijuana cigarettes/ 
week) users had decreased activity in the ri ght latera l orbitofrontal 
cortex and the right dorsolateral prefrontal cortex, and increased 
activity in the left cerebellum, compared to the contro l group, during 
a decision-making game.15 Another imaging study, using transcranial 
Doppler sonography, showed increased cerebrovascu lar resi tance in 
chroni c li ght to heavy users.16 However, these studies were small , 
with II and 54 subjects, respectively. One meta-analysis of tudies 
tota lling 623 chron ic marijuana users fo und that a lthough these 
indi viduals may show decreased ab ili ty to learn and remember new 
inforn1ati on in the long tern1, other cogniti ve proces es were 
unaffected. Thus, while there may be neurophysiological and 
neurovascul ar effects of chronic marijuana use, some of these effects 
may be sil ent. 
Marijuana use has been shown to have negative psychological 
consequences, specifica ll y an increased ri sk of psychosi . It is 
poss ible that cannabinoids ' effects on dopam ine release contribute to 
the onset of psychosis.17 A ystematic rev iew of 35 popu lat ion-based 
longitudinal stud ies concluded that individuals who had ever used 
marijuana had an increased risk of developing p ychosis later in life . 
18 Furthermore, a dose-dependent relationship was observed where 
heavier users had a further increased ri sk of psychosis (adj usted OR 
1.41 , 95% CI 1.20- 1.65 vs. 2.09, 1.54-2.84, respectively) . Of course, 
a possible interpretat ion of these re ults is that an underlying, 
undi agnosed psychotic disorder leads to cannabis u e, which 
faci litates the di scovery of the pre-exi ting psychological illness. 
Similarl y, the oft-c ited 'amot iva tional syndrome,' in which the 
sufferer is chronica lly unproducti ve, a imless and unmoti vated, is 
assoc iated with chronic marijuana use. One study found that 
indi viduals who have used marijuana a minimum of 5000 times were 
signifi cantly less likely to graduate from co llege and less likely to 
earn more than $30 000 (US) per year.19 However, like psychosis, 
thi s may be explained by the presence of many confounders 
inc luding pre-ex isting depression. Gruber et al. have recently 
published data indicating significant alterations in fronta l white 
matter tracts in chronic marijuana smokers. The authors suggest that 
these changes are associated with increased impulsivity, whi ch may 
contribute to the initiat ion of chroni c marijuana use or the inabili ty to 
di scontinue use20 
HEALTH PROMOTION 
Risk factors for marijuana use and abuse: Risk factors for 
marijuana use include male gender and age 18-25 , while risk fac tors 
for dependence, defi ned a a maladapti ve pattern of use despite 
negati ve effects, increa ed use, unsuccessfu l attempts at cessation 
and physiologic withdrawa l, include male gender, age 12- 17 and 
absence of post-secondary edu cati on4 Stinson et a l. 2 1 have 
underscored that cannabis abuse and dependence are genera lly 
phenomena of adolescence and young adulthood, and onset of 
dependence after age 30 is rare. Stinson et al. 's results confirmed 
that, unlike w ith alcohol (where ri sk of dependence persists for 
decades after first use) , there is a shorter developmenta l peri od of 
risk for cannabis dependence. As such, there is a window of 
opportunity in ea rl y adolescence for the implementati on of 
preventi on and intervention programs, in order to have max imum 
impact. A pro pecti ve longitudinal study of a community sample (n = 
302 1) aged 14-24 years in Munich, Gennany,22 found that 56% of all 
repeated cannabis users (five times or more) still reported cannabis 
use at 4-year fol low-up . At 10-year fo ll ow-up, thi s proportion had 
decreased only sli ghtl y to 46 .3%. Among youth who are repeated 
cannabis u er , patterns of use remain table, and rates of cessation 
are low, until age 34. Such patterns suggest that preventi ve measures 
should de lay first use and reduce the number of uses, as these factors 
appear cruc ial in the transi tion to persistent and dependent use of 
cannabis.22 
A lthough males may have hi gher rates of marijuana use, Schepis 
et a l. 23 have suggested, based on results from a cross-sectional survey 
of Connecti cut adolescents, that females may have a more rapid 
tran ition from initi al marijuana use to regul ar or dependent use. The 
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authors also suggested that marijuana use was associated, not 
surprisingly, with ri sk behaviour participation (e.g. other substance 
abuse) and that partic ipation in extracurricular activities was 
protective agai nst marij uana use. A prospective cohort study of Swiss 
teenagers and young adu lts was performed to evaluate different 
lei sure time acti vities and the persons (e.g. partner, friend, sibling) 
with whom the acti vities were undertaken24 The choice of 
companions for leisure act ivity was more important than the activity 
itse lf as a predictor of initi ation and progression of cannabi s use, 
supporting the widespread view that peer influences are particularly 
important in young people 's risk behaviour . This finding was 
reinforced by data from the German study18 ci ted above, in which 
peer use of cannab is, stressful life events and alcohol dependence 
predicted long-term marijuana use. 
Marijuana and tobacco: Health promotion for marijuana cessation is 
parti cul arl y important g iven the hi gh co-morbidity between 
marijuana and tobacco use, and the potentia lly damaging interact ion 
of these two ubstances on respiratory outcomes. Leatherdale, 
Hammond, Kaiserman et at.25 described results from a 2004 tobacco 
use survey of 20,000 young adu lt Canad ians (aged 15-24). The rates 
of marijuana use were highest among current tobacco smokers, and 
lowest among youth who had never smoked. Those who use 
marij uana are less likely to quit smoking (odds rati o 1.94); those who 
use marijuana dai ly are even less li ke ly to quit than those who have 
used at some point in the past 30 days 26 Thus, whil e marijuana use 
itself may or may not be assoc iated with an increased ri sk of lung 
cancer, marijuana use may secondaril y increase the ri sk of lung 
cance r through its assoc iati on with persistent to bacco use . 
Conversely, through use of prospecti ve survey methodology, Schaub 
et at.2° found that nicotine use increases the ri sk for both the 
initiation and the progression of cannabi s use. The authors also 
reported that tobacco use remai ned high even afte r reduction or 
cessation of cannabis use. Thus, there appears to be a bidirectiona l 
ri sk between tobacco and marij uana use, with use of either substance 
increasing the likelihood of using the other. Clini cians should ask 
about marijuana hi story and take marijuana use into account when 
recommending tobacco smoki ng cessati on measures for the ir 
patients, and vice versa. 
Mental health disorders and use of cannabis: A study of 884 1 
Australian adults aged 18- 85 year found that participants wi th 
affecti ve disorders and anxiety di sorders were at increased ri sk of 
harmful drug use and drug dependence.27 This corre lation was 
particularly strong for you ng males, a group already identified earli er 
as high-ri sk for marijuana dependence. Another study reporting on 
cannabis use disorders and mood and anxiety disorder co-morbidity 
showed that bipolar disorders, panic disorder with agoraphobia, and 
generalized anx iety disorder had the strongest associa ti ons wi th 
cannabis abuse and dependence. 17 Whi le the directionality o f thi s 
association remains unclear, one theory is that the experi ence of 
untreated affective disorders and anxiety disorders may lead to se lf-
medi cati on with psychoactive substances such a marijuana. A uch, 
it is important for hea lth practitioners to identi fy and treat underl yi ng 
mental hea lth conditi ons in a timely and effective manner. Indeed, 
there is evidence that such practi ces can reduce marijuana use, as 
demonstrated by two randomized controll ed tri als included in a 
systematic rev iew.28 For exampl e, in a flu oxetine treatment group, 
cannabi use decreased in patients with depression. In patients with 
psychotic disorders , both olanzapine and ri speridone treatment 
groups also reduced cannab is use. From a health system-level 
perspecti ve, overcoming the treatment fragmentation between mental 
health and drug and alcohol serv ices would mean that the issue of 
comorbidity among clients (particularly young people) can be more 
adeq uately addressed.7 
Treatment of marijuana use disorders: Despite public perceptions 
of marijuana as a relative ly innocuo us drug, exposu re. to 
psycho acti ve cannabinoids can induce st ro ng drug- seek mg 
behaviours; these are mediated by increased dopamine release m the 
brain 's reward pathway.29 Abrupt withdrawal of cannabm01ds after 
long-term exposure can produce dysphoric effects, wh1.ch ~ay 
contribute to relapse. Although cannabis shares neurobwlog1cal 
features associated with depe nde nce on othe r drugs , on ly 
approximately one-tenth of individuals who abuse cannabiS had ever 
rece ived treatment. 17 Psychosocial interventions, although effect1 ve 
in the short-term, often lead to long-term relapse, and the ava tlable 
behavioural treatments are only modestly effective. As such, there IS 
a need to develop pharmaco logical intervention , and currently none 
have been validated through clinical trial s.25 
As described above, cogniti ve impairments may not be fully 
reversible even I month after cessation of marijuana use. It remains 
unclear if these findings refl ect long-term effects of marijuana, or 
si mply an impairment of baseline cognitive functioning in marijuana 
users. Nonetheless, cogniti ve impairments in marijuana users may 
result in poor treatment response,3° particularly in light of the lack of 
motivation and increased impu lsivity that is associated wi th chronic 
marijuana use. Studies have suggested that cho linesterase inhibitors 
may ha ve a ro le in improving cann ab is- induced cognitive 
impairments, but these drugs have not yet been evaluated in humans 
for the treatment of marijuana dependence. Cogniti ve rehabilitation 
has improved function and treatment outcomes in individuals 
addicted to other drugs. ofuoglu et al. have thu suggested that 
improving cogniti ve function may serve as an important treatment 
strategy for marijuana use disorders2 6 
Harm reduction through use of vapo urizers : Given the 
widespread use of marij uana, the increasing abuse and dependence 
on this sub tance, and the paucity of effective treatment trateg ies, it 
is important to consider harm reduction approaches to mitigate 
marijuana' potential adver e con equences. This pragmatic approach 
is particul arly compelling given marijuana 's increasing use for 
medicinal purpo es. Accord ing to resu lt from a 1998 Canadian 
survey, medica l use of marij uana was less common than its 
recreational use (2% versu 7%),31 but thi picture may change in 
light of the shi ft ing legal landscape surrounding medic inal marijuana. 
Cannabinoids acti va te the arne neurotransmitter pathways as 
endocannab inoids, produci ng effects ranging from analgesia to 
appetite stimulation to nausea reduction . They al o cau e a reduction 
of intraocular pressure, hence the usefulnes of marijuana in treating 
the ymptoms of g laucoma.32 The main challenge for the medi cal 
u e of cannab ino ids is the deve lopment of safe and effective methods 
of use th at lead to therapeutic benefi t, without respiratory 
consequences or other adverse effects. 
Ea rl eyw ine and Barnwe ll 11 ha ve described the use of 
vapourizers among marij uana smokers : vapourizers release active 
cannabino ids but not smoke o r carcinogens a sociated with 
combu tion . The use of a vapourizer is assoc iated with decreased 
respiratory symptoms, and this effect increases with the amount of 
cannab is used. Furthem1ore, vapourizer can deliver ca nnabi s with 
no carci nogeni c potenti a l. This has important implications for safe 
use of. medica l marijuana as well as harm reduction among 
recreatwnal smokers. In one study, twenty frequent cannabi s users 
who reported respiratory complaints were eva luated before and after 
the use of a vapourizer for one month33 Among participants who did 
not develop a respiratory illness during the trial , there was a 
s ignificant improvement in respiratory symptoms and FVC and a 
non- ignifi cant improvement in FEY I . These improvements c~u ld be 
even more meaningful in cannabi s users who al o smoke tobacco 
The . authors c?ncluded, given . these. ~eani.n gfu l recovery of 
resptratory functiOn, that a randomized cltnt ca l tn al of the cannabis 
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vapourizer should be performed. The vapourizer has potential for the 
administration of medical cannabis and as a harm reduction 
technique, particularly for those uninterested in marijuana cessation 
or who have been chronic, heavy users. 
CONCLUSION 
Although the prevalence of marijuana use has not changed 
sign ificant ly in recent years, the higher cannabinoid content of 
current plants may be contributing to the observed increase in rates 
of dependence in ado lescents. Both phenomena - increased dose of 
psychoactive drug, and increased rates of serious dependence - have 
catalyzed more research into the long-term neuropsychi atric effects 
of marijuana use. Long-term marijuana use is associated with an 
increased risk of psychosi s and 'amotivational syndrome '. However, 
the direction of causation remains unclear, not least because the risk 
of marijuana dependence during ado lescence is clearly increased by 
co-morbid psychiatric di sorders and has been characterized as a fonn 
of 'self- medication '. Marijuana is also associated with specific long-
term cogn itive abnormalities; the possibility of reverse causation 
seems remote for these findings, but further research is needed. 
Marijuana has immediate adverse effects on respiratory mucosa 
simi lar to tobacco; however, evidence for chronic respiratory disease 
re lated to marijuana is weak. For lung cancer, imilarly, heavy 
marijuana use produces metaplastic changes but there is no 
compelling evidence for an association with clinical di sease. The 
contradictory evidence for both conditions may reflect differences in 
the chemistry and cellular effects of marijuana as contrasted with 
tobacco, as well as the high frequency of joint exposure. In that latter 
regard, the more significant risk for respiratory illness, including 
malignancy, may arise from the strong association of tobacco and 
marijuana use, and the reduced likelihood of smoking cessation in 
the presence of joint dependence. 
From the standpoint of health promotion, we can draw a number 
of key conclusions. Primary prevention of marijuana dependence wi ll 
require health education targeting pre-adolescence. The preva lence of 
comorbid psychiatric disorders in dependent adolescents highlights 
the need for an integrative approach to treatment and secondary 
prevention. Awareness of the conjoint use of tobacco and marijuana 
is important for clinicians seeking to promote smoking cessation. 
Lastly, vapourizers have the advantage of mitigating respiratory ri sk 
and may serve as an effective harm reduction strategy for those who 
are chronica lly dependent or using cannabinoids for clinica l 
indications. 
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An Interview with Dr. David Leasa 
Lauren Sham (Meds 2014}, Abdu l Naeem (Meds 2014}, Joyce TW Cheung (Meds 2013} 
T ln disaster management, where etiologie of disease can be unknown and every second is of the essence, a well-functioning intensive care unit (LCU) is paramount. The 
SARS (Severe Acute Respi ratory Syndrome) outbreak in 2003 
highlighted the importance of efficiency in meeting the challenges of 
medical urgencies. In an area where resources are limited, cri ses 
exacerbate chall enges with staffi ng shortages and bed reductions, 
compounded by disease transmission within the lCU , staff 
quarantine, emotional stre , and a constant influx of criti ca ll y ill 
patients I. However, the 2003 outbreak also presented itself as an 
opportunity to improve critical care delivery, with respect to 
implementing better infection control measures, developing software 
for handheld devices specific for SARS, and having regul ar 
teleconference call s to both combat the feelings of iso lation and 
increase information dissemination on this unknown illness 1• One 
needs passion and proficiency in handling "acute medica l problems 
where problems often come in undefi ned," says Dr. David Leasa, a 
London, Ontario based ICU phys ician. 
Dr. Leasa was born and rai ed in Waterloo, Ontario, and studied 
Physiology and Pharmaco logy at the University of Western Ontario 
(UWO). He continued hi s studi es at UWO 
in medicine and completed hi s internal 
medicine residency there as well. After 
specializi ng in Respirology and Critica l 
Care he moved to Seattle, Washington to 
pursue a year of research. He moved back 
to Canada, worked at St. Joseph's Hospita l 
and later moved to University Ho pita! 
where he is currentl y working as an I U 
physician and Respirologist. When not in 
the hosp ita l, Dr. Leasa enj oys being 
outdoors. He likes to ki (even hope for a 
retirement in Whi stler!), swim, and run - a ll 
act ivities he fee ls help him lead a balanced 
healthy li fe. 
Being a n ICU phys ician and a 
Respirologist is demandi ng. Dr. Leasa leads 
a very act ive and busy work life. He tends 
to have a week of "days" ( 12 hour shifts) in 
I U, alternating with a week of "ni ghts," 
and is on-ca ll some weekends. During 
ni ghts, a new initi ative is in place where the 
ICU staff has criti ca l care ou treach . 
Qualified ICU ph ys icia ns extend their 
experti se to other departments if they fee l a 
patient might end up in the ICU . By 
extending their services outside of the ir 
usual boundari es, they are ass ist ing patients 
earli er, wi th the ai m of preventing ICU admi ssions. He also has a 
week in Extended ICU (E ICU) where he provides care for patients 
needing prolonged ventilator care for greater than three weeks. In 
addition to ICU, he spends one week every 2 months on the 
Respirology service taking consult . Finally, he also has a chest clinic 
that is evolving into providing care for chronica lly venti lated 
patients. 
In the ICU, Dr. Leasa empha izes, "You need to have a team of 
people put forth what is the best management for that individual." 
This team approach reflects the dynamics on the wards. ln the ICU, 
all the physicians come fro m different pecialties but have added 
skills in critical care. (Critical care is an additional two-year RCPSC 
subspecialty after having completed a base specia lty.) Dr. Leasa 
admits that a he gets older, ICU may be too demanding (especially 
nights!) and that it wi ll be nice to be able to fa ll back on his 
outpatient pract ice. He enjoys chatting with hi s patients and meeting 
people in this sett ing. This prov ides continuity with patients who get 
very ill initia lly, but he can follow and see them in a different etting 
as they recover - see thei r per ona li ty and who they are as 
indi viduals, omething he cannot alway experi ence in the !CU. 
However, hi s pass ion has a lways been 
intensive care. He enj oys managing and 
problem- o lving acute care Res pirology 
ca es in the ICU , fro m pneumonia to acute 
re piratory distress syndrome (ARDS), to 
broncho copies and pleural effu ions. 
Th e practice of bot h ICU and 
Respirology has led Dr. Lea a to hi s interest 
in long-tern1 mechanical ventilat ion - he is 
known as the " home venti lation doctor. " He 
i presently involved in an initiative to 
provide care for stable chronically venti lated 
patients by moving them from the ICU 
environment to other community venues, 
inc luding home if pos ibl e. Dr. Leasa 
believes that "to do it safely, properly and 
effecti vely, we need to do it using a systems 
approach." He wou ld want to not on ly 
prevent patients from ending up in the ICU 
agai n but also improve the ir overa ll qua lity 
of life through care at home or in the 
community. At the moment, he is tty ing to 
advocate that thi s initiative needs the proper 
funding: if we can prevent these patients 
from us ing ICU beds a nd shift these 
resources to the community, there wou ld be 
benefits for all. Hi s vision for this project 
Involves developmg a community-ba ed 
36 UWOMJ I 80 :2 1 Fall2011 
model for the region of Southwestern Ontario. Currentl y there are 
more than 180 pat ients who are on both non-inva ive and invasive 
ventil ation in our catchment area. Ventilator technology has changed 
dramatically over the past decade including its ease of use and 
increasing application using a noninvasive mask interface . However, 
several hurdl es remain inc luding cost, need for trained community 
careproviders and for patients/famil y members to be ed ucated and 
empowered. Dr. Leasa is currentl y trying to create a coordinated 
system of people who understand the complicated nature of the care 
for these chroni cally ventil ated patients. One important task i to 
identify and support those pati ents for whom chroni c ventilator care 
at home improves qua lity of life. Importantly, this needs to be done 
in a way that coordinates all caregivers ' skill s so that pati ents do not 
end up back in the ho pital. There are many patients that can benefit 
from this type of technology (especia ll y those with chroni c 
neuromuscu lar di sease), but in order to do thi s safe ly and effecti vely, 
a preplanned system needs to be in place, and thi s is what Dr. Leasa 
is trying to help e tabli h. 
The future of critica l care holds a plethora of possibi liti es, but 
also many difficult ethica l issues. Because patients in the ICU are 
often amongst the sickest people in the hospita l, the difficult issue of 
death and dying often arises, and proves to be a challenge for both 
families and the JCU team. Dr. Leasa believe that an important step 
in improving care for patients in the ICU lies in education on the 
taboo subj ect of dying. Due to advances in med ical technology, 
patients can be kept a li ve fo r longer than their bodies would natura ll y 
be able to ustain . Difficult issues arise when one has to cons ider the 
quality of life for a pati ent who is unconscious and unable to survive 
without the aid of sophisticated machinery. 
Dr. Leasa is not one unfamiliar with making difficult decisions. 
Recently, he bad to sit down with the family of a 95 year o ld man 
who bad a myriad of comorbiditi es, none of which were easy to 
manage. As medical students we learn: "primum non nocere," or 
"first do no harm." You would think that everyone would want to 
give this man as comfortabl e a death as possible. However, hi s 
fa mily expressed that he wanted to li ve unti l he was I 04, and wanted 
everything possib le done for him, from intubation to chest 
compressions. Perhaps it was guilt from neglect in previous fa mily 
confl icts, or a just desperation to cling onto any semblance of life 
possible, but these situations are not always as clear as they appear, 
neither to the family nor to the clini cian. 
So how do we open up and begin talking about these diffi cult 
issues? Dr. Leasa believes the family unit is critical in these 
di scussions. The difficulty in talking about the deteriorating health of 
a loved one is trying to figure out what the patient would have 
wanted for him or herself. He recall s some famili e who have not 
seen or talked to Dad in ten years but think that prolonging care is 
what he would want. As criti cal care has bettered itself with 
improved communication, so too wou ld families. Dr. Leasa lives out 
this philosophy, which was inspired by the mentors he has had over 
the years: "The physic ians I learned a lot from were those who sat 
with patients and talked honestly to them," he said, noting that they 
didn 't keep a di stance but instead liked to understand the person they 
were treating. 
As past-president of the Canadian Criti ca l Care Society (CCCS), 
Dr. Leasa has participated in many activities to enhance the quality of 
care in ICUs across the country. The CCCS has guidelines on how to 
assist in difficult issues at the bedside, as well as advocate for 
improvement of patient and family experience in the ICU. He notes 
that critical care has had its shake ups, including the SARS outbreak 
which was an eye opener for governments and health care 
professionals alike, but they learned that critical care had to be done 
as a collective. He believes that they have been doing a good job in 
Ontario2 in dealing with increased occupancies and having clear 
pl anning for surges. He notes, " If you stop criti ca l care, you stop 
everything. Everything starts to back up. " He also thi nks we need 
more di scussions on the ethical use of resources: not ju t at the level 
of the indi vidua l, but on a soc ieta l level. He poses the question , " If 
we had SA RS again, and we ran out of ventil ator and ICU beds -
what would we do? Would we use a predetennined algorithm to see 
who gets a ventil ator and who does not?" He acknowledges that it is 
difficult to have these di scus ions, but working through these 
scenarios is necessary. After go ing through SARS, politic ians fin all y 
understood it, even expressing th at "SARS was good for criti ca l ca re 
- it created outreach teams, put more nurses into the system, and 
looked at what 's go ing on with respect to resource - what they are, 
and where they are." 
Dr. Leasa be lieve that the general public needs to be better 
educated on the purpose of the ICU, but a lso that it has its limits. He 
and hi s colleagues spend a lot of their time di scuss ing what critical 
care resources can and cannot do. Education of the genera l public 
becomes increasingly important as the vo lume in the ICU increases. 
With the current advance in li fe support sy tems we are able to 
extend li fe that previously would have ended . This leads to new 
cha ll enges. He wants people to understand that we cannot cure 
everything, and we cannot always delay death. Many times patients 
are chroni ca lly ill at the end of their li ves and are in a proce s of 
dyi ng. Should ICU care and a ventilator be part of that death 
process? There is still a gap between what patients and or the ir 
fam ili es expect and what our current medi ca l technology can 
ethicall y and reasonably deli ver. Dr. Leasa is hoping we can bring the 
two c loser together. 
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A lung mass and digital clubbing in a young 
woman 
Julie Lebert (Meds 2013), Joyce TW Cheung (Meds 2013) 
Faculty Reviewers: Dr. David Leasa, Dr. S. Nelson 
I nflammatory myofibroblastic tumours (IMT), also known as plasma cell granul omas or inflammatory pseudotumours, are the most common paediatric primary lung tumours.1 Patients present 
at a mean age of 9.7 years, maki ng it an unusual adult diagnosis2 
IMTs are extremely rare, accounting for only 0.05% of all thorac ic 
procedures 3 !MT bas traditi onally been class ified as a benign 
tumour, but recent studie suggest loca lly aggressive behaviour and 
ma lig nant pote nti a14 Radi og raphica ll y, it is impossib le to 
differenti ate between an !MT and a malignant mass,4 as the 
presentation of the tumours are highly variable. IMT may be cystic or 
homogeneous, endobronchial or parenchyma1. 1 It is thought to result 
as an inflammatory reaction to an infecti on or an underl ying low 
grade mali gnancy. Patients usually present with loca l mass effects 
with or without systemic features such as fever, weight loss, 
microcytic hypochrom ic anemia, polyclonal hyperglobulinemi a, 
elevated ESR, and hypertrophi c osteoarthropathy (HOA) 2 •4 Due to 
its variable natural history, compl ete surgical excision is the 
treatment of choice.3 
CASE REPORT 
A 24-year-old female presented to our institution with a four-month 
history of left sided pleuritic chest pain . The pati ent had a hi story of 
hypochromic microcytic anemi a and was currently taki ng oral 
contrace pti ve pill s a nd iro n s uppl e me nts. Upon ph ys ica l 
examination, a review of systems revea led that she had a non-
productive cough, drenching night sweats, fatigue and had lost I 0 
pounds. She a lso reported joint pai n and morning stiffness, 
predominantl y in volving her wrists, knees and ankl es. The patient 
had recentl y fini shed a ten-day course of antibi oti cs with no 
symptomatic improvement. She was a non-s moker with occasional 
marijuana and alcohol use. Her family hi tory wa negati ve for 
mali gnancy, but her brother had asthma. 
The pati ent had tendemes to palpation over lateral chest wa ll 
on physica l examination. Bilateral clubbing of the dig its wa noted . 
Laboratory investigations revea led hypochromic microcytic 
anaemia (haemoglobin leve l of 80 g!L, a mea n corpu cular volume 
of 77.1 fL , microcytic hypochromasia). Chest plain fi lm showed a 
mass- like conso lidation in the left lower lobe with enlargement of the 
left hilum. Computed tomography (CT) showed a heterogeneous soft 
ti ssue rna extending from the lateral che t wa ll to the inferi or 
aspect of the left hilum. No cav itation or characteristic ca lci fi cation 
was identified. Small blood vessels were seen within the les ion, but 
did not have the appearance of normal lung vesse ls. The mass 
extended centra ll y to contact the inferior aspect of the left hilum . No 
lymph node, chest wa ll in vasion or rib destructi on were identified . 
Exploratory left thoracotomy with enucleation of the tumour 
was performed and an intra-operative frozen section of tumour (3 .2 x 
2.0 x 1.5 em) showed hi stology consistent with benign spindle cell 
tumour. Fo ll owing this procedure, the tumour increased in size from 
4.1 em to 5.4 em over a s ix month peri od. Thi s recurrence of the 
tumour suggested locall y aggress ive behaviour; and it was decided to 
perform a left pneumonectomy. Surg ica l patho logy showed no overt 
cytoli c atypic, however vascular invasion and invo lvement of the 
diaphragmatic ti ssue were evident. Clear resection marg ins were 
achi eved in the pneumonectomy and resecti on of di aphragm. 
Adjuvant chemotherapy or radiat ion was not recommended . 
DISCUSSION 
Clinical manifestations 
Inflammatory myofibroblastic tumour (I_MT) is a rare tumour that is 
mo t commonl y a ociated with the paedi atric population. Numerous 
studies, however, bas shown that IMT can affect people of any age 
and equally affects both gender .2.4 It i a lso important to note that 
IMT can occur throughout tbe body. In a review of 44 pati ents with 
IMT, Ko ach et a l. reported IMT occurring in the liver, gallbladder, 
orbit, mediastinum, neck soft tissue, trachea, bowel , brain and others. 
4 The organ wi th the highest frequency of diagno is is the lung (9 of 
the 44 patients) 4 
The presentation of IMT depends on the location of the tumour 
and i influenced by local mass effects from the tumour size.4 IMT 
can present with a variety of symptoms, both systemic and localized, 
uch as anaemia, weight loss, feve r, pain, and mas .2 For example, in 
thi s case, the patient presented with pleuritic chest pain . 
The lung is the most common location of this neoplasm but has 
been reported to present with extrapulmonary symptoms . There have 
only been a small number of case reports where hypertrophic 
osteoarthropathy (HOA) was ob erved .5·6•7 Furthermore, these cases 
occurred in children with no reported adult cases with HOA. The 
etiology o f HOA in assoc iation with IMT of the lung is unknown.5 
Pathology 
Inflammatory myo fibrobl astic tumours pathologically consist of 
myo fibrobl a tic spindle cell s with an inflammatory ce ll infiltrate.5 
The appearance of IMT under microscopic examination is variable 
both between the different site of occurrence and between patients 
with tumours in the same location .4 
The etiology of IMT is still under debate and current opinion is 
changing as new information, especia lly genetic analysi of the 
tumour cell s, comes avai lable. It was initia lly proposed that IMT 
arises from uncontrolled, excessive immune response to ti ssue injury 
(most likely from infection); however, more recent studi es suggest 
that it might in fact be a true mali gnancy.4•8 Thi s is supported by 
reports of distinct mutations in the cell s of these tumours and by the 
tendency for local recurrence and invasion , distant metastas is and 
potentially sarcomatous degeneration .3.4.S 
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Diagnosis 
A diagnosi s of IMT impossible to determine c linically as it is 
genera lly a di agnosis of exclusion. Upon imaging, a mass wi ll 
typically be identified; however si nce IMTs occur with a wide range 
of radiol ogical characteri stics, imag ing does not often contribute to 
the diagnosis 9 Radiologica l reports on IMT, show that these tumours 
can be cystic or homogenous, endobronchial or parenchymal, and 
with or without clear margins.9 These qualities make IMT difficult to 
distingui sh fro m infectious or malignant pathologies.4·9 Furthermore, 
biopsy of these les ions rarely results in a conclusive diagnos is, as 
IMT can mimic many other pathologies such as fibrous hi stiocytoma, 
leiomyosarcoma or fibrom atosis.2 A confident diagno is can thus 
only be made fo llowing surgical resection and pathological anal ysis 
of the mass . s 
Treatment 
There are several treatment options to consider after IMT is 
diagnosed. The first line treatment is surgical exci ion since IMTs 
have the potential to local recur, be loca lly invas ive, and occasionally 
metastasize. Other suggested options include NSA IDs, steroids, 
radiation, chemotherapy and observation only. 
In a retrospective study, 25 patients had complete resecti on of 
the tumour.3 The 30-day post-operative mortality was 4% and 
morbidi ty was 8%.3 The 10-year surviva l was 89%, with one 
patient's death due to extensive sarcomatous recurrence 2 years post 
surgery.3 This study demonstrates that IMT has an exce llent 
prognosis with complete surgical excision, however must still be 
considered a malignancy with the potential to have di stant metastasis, 
local recurrence and sarcomatous degeneration .3 
While surgery has shown po itive results in patient cure rates, 
the natural hi story of IMT has not been well studied 4 In a case 
series, it was noted that local recurrence occurred in 8% of pat ients 
where resection was attempted4 Local recurrences tended to occur 
where complete resection of the tumour was not possible or where 
radiation or chemotherapy was not received 4 
CONCLUSIONS 
IMT is more common in the paediatric population and rare in adu lts. 
However, it should be considered on the differential diagnosis when 
a mass presents in a non-smoking adult.8 
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T he Canadi an medica l tudent, much like the Canadian publi c, is proud of its healthcare system but believes it is in need of enous reform.1 The perception is o ften that cost are 
increasing to unsustainab le levels, with the conundrum that the 
y tern still doe not deli ver a much a it hould, to as many as it 
should, or in a timely enough fashion2 In a 2011 national survey, 
only 5% graded the hea lthcare y tern a excellent. However, less 
than a third of a ll respondents be li eved they had a strong 
understanding of how the healthcare ystem worked 3 How can one 
properly rate a system they do not understand? While medica l 
students have a bas ic practical understanding of the medica l system, 
they are found lacking when it comes to the economi c theorie and 
principles that govern hea lthcare.4 Thi s i not surpri sing given the 
very limited time that can be allocated out of packed medi ca l 
curriculums5 The concern nevertheless remains that medical students 
may be unequipped and unprepared for their future rol e in 
hea lthcare resource a ll oca tio n and management. Witho ut an 
appreciation o f some basic tenet of hea lthcare economics, having a 
healthy discussion, taking a positi on, and making a well- in fo rmed 
deci ion on issues o f hea lthcare system will be diffi cult. The 
purpose of this primer is to introduce to the medical student the most 
fundamental economi c concepts and how they are pertinent to 
healthcare. Ultimately, it will be up to the students themselves to 
buttress their knowledge in thi increas ing ly important subject area ; 
thi s editori al can only hope to whet the palate just enough to 
encourage further ex ploration. 
HEALTH CARE IS A SCARCE GOOD 
The fundamental problem that underlines the study o f economi cs is 
ba ed on the s imple premi e that resource are finite whil e human 
needs are infinite6 When thinking about a tangibl e good uch a 
foss il fuels, the idea is easy to grasp. Everyone want an unlimited 
supply of fossil fu els to power their generators and run their 
machines. However becau e thi re ource i ca rce, there need to be 
a system that decides the a ll ocati on: namely who gets it and how 
much they can get. Economists concern themselves over the best way 
thi s a ll ocation shou ld be made, and a k themse lves how thi 
a ll ocation can be the mo t effi c ient while at the same time the most 
equitabl e. 
When it comes to any good produced in the economy, even one 
as complex as healthcare, the fundam ental problem sti ll remains. The 
producti on of healthcare require the mu lti tude o f raw materia ls and 
suppli es required for equipment and facilities. In addition, it requires 
the time and tra in ing of healthca re worker .1 All of these, including 
time, are ca rce resources. Indi viduals se ll their time for wages and 
will even re fu se work and wage if it " isn' t worth their time." People 
view their time as a va luable resource that if used for work, can no 
longer be used for other acti viti e such as le isure.6 In much the arne 
way, once scarce resources are devoted to the production of 
healthcare, they can no longer be used in the production of other 
valuable goods. Each joule of energy used to power a Magnetic 
Resonance Imaging (MRI ) machine is one that cou ld have been used 
to power a school. Each year tra ining one doctor cou ld have been 
used to tra in several economists. (It takes more resources to train a 
doctor than an economist). 
One aspect of macroeconomic theory tries to determine how a 
nation's scarce resources should be best a llocated between its variou 
sectors. When policymaker decide on more MRJs and increasing the 
number of residency spot , it means we have to g ive up more of 
something else. Consider the foll owing: Canada 's Gross Domestic 
Product (GDP) has increased an average of 1.7% ann ually over the 
last decade.8 GDP i a measure that adds up a ll the goods and 
services that an economy produces per year. This indicates that on 
average, the Canadian economy grew by I . 7% each year over the last 
decade. The healthcare sector has increased by an a erage o f 4.7% 
annually over a s imilar period.9 If the entire economy is viewed as a 
pi e, then this mean that while each year the pie get a little bigger, it 
has not been able to keep up with the increasing s ize of the 
hea lthcare lice. If more of the pie is being di tributed to healthcare, 
then less is left over fo r va ri ou sectors such as educat ion 
agriculture, or high-tech indu try. Everyone rea li ze that healthcare i ~ 
important. The difficult questi on is how important. If for example, 
we va lue an additi onal unit of hea lthcare more than an addit ional unit 
of national de fense, then foregoing more de fen e for increased 
pending on hea lthca re benefit oc iety. If our value were reversed 
then additional spending on hea lthcare would result in Ie s sociai 
bene fit. Deciding how much a nati on should spend on hea lthcare is a 
difficult question beca use it ca ll into question our value and forces 
u to a k how much we va lue hea lthcare over everything el e. 
ECONOM ICS A A SOCIAL SCIENCE: UNDERSTANDING 
THE POWER OF INCENTIVES 
While the fi e ld o f modem economi cs relies on a empirical-based 
approach with tati stical analys is, the fi e ld has it roots in the ocial 
sc iences. At its hea11 lies the desire to understand the decision 
making of individua l in their production or consumption of goods or 
erv1ces 6 Economists assume that decision makers are rational and 
make choices that be t further their own ends. By under tanding the 
mcenll ves that indi vid uals face and how these then motivate a 
particular course of action, economists can predict and there fore 
model the outcomes.6.7 
. . When thi s modeling i app lied on a larger cale to group of 
md1V1dual s, economists hope to better understand and predict the 
consequences 111 the economy based on changi ng incentives. For 
example, . when it comes to physicians deciding the ir location for 
pract .. ce, 1ncen t1 ves ~lay a hug~ ro le .7·10 As recently as 2006, 1 in 9 
phys1c1ans educated 111 a anad1an med1ca l schoo l practiced in the 
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United States. 10 Therefore, they contributed nothing to the production 
of healthcare in Canada. In trying to understand and reverse thi s 
phenomenon, anadian economist and poli cymakers have identified 
a number of incentive at play. The most famili ar is the remunerati ve 
differenti al with the appeal of higher net income in certain specialti es 
in the US (due in part to their lower taxation rates). 'o By identi fy ing 
the pertinent incenti ves, policymakers can dev ise new strategies to 
alter them. 
However, policymakers al o need to be care ful due to the 
unde irable con equences that may result when all incenti ves have 
not been taken into accoun t. In many cases, hidden incenti ves are 
overlooked and lead to unintended consequences. For example, in 
the physician-patient relation hip, the phy ician is not onl y an agent 
hired to act in the be t interest of the patient but is also the sell er of 
health ervices.7 In a fee-for-service compen ation method, the idea 
is to compensate the physician based on the services the patients 
receive. Phys ician who perform more services are thought to 
provide more healthcare and should be compensated accordingly. 
However, since the income of the phy ician is linked to how many 
services he or she provides, there is an incenti ve to promote more 
procedure than would otherwise be nece ary.11 These additional 
services are not only wasteful fo r the economy and lower effi ciency, 
but they may in fact do harm by leading to poorer outcomes in 
patient who receive superfluous procedures.7•11 
HOW TO COMPARE APPLES AND ORANGES: VALUATION 
AND COST-BENEFIT ANALYSIS 
The focus of hea lthcare di scussion is frequentl y directed at curbing 
the ri sing costs, and this cost cri sis of hea lthcare dominates the 
headlines.12•13•14 It sometimes becomes easy to forget that we value 
hea lthcare because we want more of its output: health itself. The 
va lue of healthcare is not in the number of patient appointment or 
pill s prescribed, but in the number of li ves saved and the 
improvement in health outcome. By placing a va luation on health , 
the important outcomes such as quanti ty and qua lity of life can be 
mea ured and expressed. If two medica l intervention have 
equivalent cost, and intervention A can add 3 years to life expectancy 
and intervention B only adds one year, it becomes quite clear which 
is superior. In evaluating any project or program, it is important to 
compare the va lue of what was bought to its cost. Economists use 
this principle of cost-benefit analysi when evaluating healthcare 
programs.7 
When applied on a larger sca le, it offers the potential for 
comparing different healthcare interventions and even comparing 
program in health and non-health sectors. Noti ce that the 
interventions in the examples above could have been completely 
unrelated . Intervention A could be a cancer fi ghting drug and 
intervention B a surgical procedure for coronary heart di sease. By 
placing a valuation on both the inputs (the costs of production) and 
the outputs (the benefits of health improvement) , unrelated 
interventions can be compared. Through a comprehensive cost-
benefit evaluation, economic analysis can help policymakers make 
difficult deci sions such as which projects to all ocate more resources 
into, assessing whether a new intervention is superior to the old 
standard, and in choosing between comparable alternatives7, l6 If 
applied across all healthcare sectors, policymakers can transfer 
funding from high-cost low-benefit programs with the reallocation of 
these resource into low-cost high-benefit programs. By minimizing 
costs and maximizing benefit, the overall effect has to potential to 
improve efficiency in the system and increase productivity.7·15 
CONCLUSIONS AND LIMITATIONS 
Economic principles and methods offer an approach to addressing 
healthcare problems. Many observers claim that economics is 
irrelevant to the study of health and some have argued that health 
care is fundamenta lly so di fferent from other good that fina ncial 
incenti ves do not play much of a role. Many will argue that when 
dea ling with life and death, hea lthcare consumers cannot be expected 
to maintain rati onal thinking7·15 Empirical evidence suggests thi s is 
too extreme a posi ti on.? Price and financial incentives definitely do 
influence both the production and the consumption of hea lthcare. The 
more challenging questi on is to what ex tent it doe . The hea lthcare 
sector has a unique combinati on of fea tures: the prominent public 
sector, restri cti ons on competiti on, and lack of informati on. 
Combining this with the ex tensive uncertainty that ex ists both in the 
suppl y and demand side of hea lthcare complicates economic 
analyses. 7 With certain good , both suppli er and consumer have a 
good understanding of the product. For example, with orange j ui ce, 
upplier know how many oranges are needed to produce the juice 
and are confident of the quali ty of the juice, and consumers know 
how much sati sfaction they will rece ive when drinking a unit of the 
juice. With hea lthcare, both the phys icians and pati ents are often 
uncertain of the outcomes. Rheumatologists are often uncertain of 
how pati ent will respond to a parti cular anti-infl ammatory and 
pati ents themselves are un ure of the benefit to their length or quali ty 
of li fe . With di fficulties in measuring outcome and va luation, the 
accuracy of the analy is can often be ca ll ed into questi on. In the end, 
modeling can only be as good as the informati on input. Nevertheless, 
economic principles and their methods can be a powerfu l and 
important tool when thinking about is ues in hea ltbcare. One imply 
has to realize that li ke all too ls, economic analysis in hea lthcare is 
imperfect and subject to limitations. 
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